KR20090103823A - Anti-aging agent external preparation for skin, and food and drink - Google Patents
Anti-aging agent external preparation for skin, and food and drinkInfo
- Publication number
- KR20090103823A KR20090103823A KR1020090026398A KR20090026398A KR20090103823A KR 20090103823 A KR20090103823 A KR 20090103823A KR 1020090026398 A KR1020090026398 A KR 1020090026398A KR 20090026398 A KR20090026398 A KR 20090026398A KR 20090103823 A KR20090103823 A KR 20090103823A
- Authority
- KR
- South Korea
- Prior art keywords
- fermented
- extract
- skin
- extracts
- fermentation
- Prior art date
Links
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 55
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 235000013305 food Nutrition 0.000 title claims abstract description 24
- 239000000284 extract Substances 0.000 claims abstract description 139
- 230000000694 effects Effects 0.000 claims abstract description 41
- 230000001737 promoting effect Effects 0.000 claims abstract description 34
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 21
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 claims abstract description 21
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 claims abstract description 21
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 20
- 102000016387 Pancreatic elastase Human genes 0.000 claims abstract description 20
- 108010067372 Pancreatic elastase Proteins 0.000 claims abstract description 20
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 19
- 210000001626 skin fibroblast Anatomy 0.000 claims abstract description 18
- 241000609240 Ambelania acida Species 0.000 claims abstract description 13
- 239000010905 bagasse Substances 0.000 claims abstract description 13
- 210000003491 skin Anatomy 0.000 claims description 49
- 238000004519 manufacturing process Methods 0.000 claims description 25
- 102000012422 Collagen Type I Human genes 0.000 claims description 21
- 108010022452 Collagen Type I Proteins 0.000 claims description 21
- 210000005175 epidermal keratinocyte Anatomy 0.000 claims description 21
- 240000006891 Artemisia vulgaris Species 0.000 claims description 20
- 102100030944 Protein-glutamine gamma-glutamyltransferase K Human genes 0.000 claims description 20
- 108010058734 transglutaminase 1 Proteins 0.000 claims description 20
- 241000508269 Psidium Species 0.000 claims description 19
- 230000006378 damage Effects 0.000 claims description 19
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 18
- 235000013976 turmeric Nutrition 0.000 claims description 18
- 230000037319 collagen production Effects 0.000 claims description 16
- 230000001076 estrogenic effect Effects 0.000 claims description 16
- 238000011084 recovery Methods 0.000 claims description 16
- 230000002401 inhibitory effect Effects 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- 235000008612 Gnetum gnemon Nutrition 0.000 claims description 6
- 240000000018 Gnetum gnemon Species 0.000 claims description 6
- 238000000855 fermentation Methods 0.000 abstract description 73
- 230000004151 fermentation Effects 0.000 abstract description 73
- 239000003795 chemical substances by application Substances 0.000 abstract description 48
- 230000035755 proliferation Effects 0.000 abstract description 29
- 230000037303 wrinkles Effects 0.000 abstract description 6
- 230000009759 skin aging Effects 0.000 abstract description 5
- 230000009467 reduction Effects 0.000 abstract description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract description 4
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract description 3
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract description 3
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract description 3
- 239000001138 artemisia absinthium Substances 0.000 abstract description 3
- 235000013929 Psidium pyriferum Nutrition 0.000 abstract description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 abstract description 2
- 229910052709 silver Inorganic materials 0.000 abstract description 2
- 239000004332 silver Substances 0.000 abstract description 2
- 235000011468 Albizia julibrissin Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 244000111056 Chinese albizia Species 0.000 abstract 1
- 244000236580 Psidium pyriferum Species 0.000 abstract 1
- 230000037380 skin damage Effects 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 description 83
- 210000004027 cell Anatomy 0.000 description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 30
- 238000002835 absorbance Methods 0.000 description 29
- 238000000605 extraction Methods 0.000 description 29
- 239000000047 product Substances 0.000 description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- 230000000670 limiting effect Effects 0.000 description 20
- 230000005764 inhibitory process Effects 0.000 description 18
- 239000000203 mixture Substances 0.000 description 18
- 239000002994 raw material Substances 0.000 description 17
- 239000002904 solvent Substances 0.000 description 14
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 230000009471 action Effects 0.000 description 9
- -1 aliphatic ketones Chemical class 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 229940088598 enzyme Drugs 0.000 description 9
- 238000011534 incubation Methods 0.000 description 9
- 238000010998 test method Methods 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 8
- 238000004364 calculation method Methods 0.000 description 8
- 239000000469 ethanolic extract Substances 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 235000013399 edible fruits Nutrition 0.000 description 7
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 230000004888 barrier function Effects 0.000 description 6
- 229920001436 collagen Polymers 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 235000015872 dietary supplement Nutrition 0.000 description 6
- 230000002500 effect on skin Effects 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 6
- 108010014258 Elastin Proteins 0.000 description 5
- 102000016942 Elastin Human genes 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 229920002549 elastin Polymers 0.000 description 5
- 210000002950 fibroblast Anatomy 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 239000012046 mixed solvent Substances 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 238000000134 MTT assay Methods 0.000 description 4
- 231100000002 MTT assay Toxicity 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 240000000111 Saccharum officinarum Species 0.000 description 4
- 235000007201 Saccharum officinarum Nutrition 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- 235000015165 citric acid Nutrition 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 235000012149 noodles Nutrition 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 235000013599 spices Nutrition 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 108010076876 Keratins Proteins 0.000 description 3
- 102000011782 Keratins Human genes 0.000 description 3
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 3
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 229940011871 estrogen Drugs 0.000 description 3
- 239000000262 estrogen Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 229940054269 sodium pyruvate Drugs 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- 241000972773 Aulopiformes Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- 102000029816 Collagenase Human genes 0.000 description 2
- 108060005980 Collagenase Proteins 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 239000004278 EU approved seasoning Substances 0.000 description 2
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 2
- 240000008620 Fagopyrum esculentum Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 108010076557 Matrix Metalloproteinase 14 Proteins 0.000 description 2
- 102100030216 Matrix metalloproteinase-14 Human genes 0.000 description 2
- 102000005741 Metalloproteases Human genes 0.000 description 2
- 108010006035 Metalloproteases Proteins 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229960002424 collagenase Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000005238 degreasing Methods 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 235000019688 fish Nutrition 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 235000020710 ginseng extract Nutrition 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 230000003780 keratinization Effects 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 235000021067 refined food Nutrition 0.000 description 2
- 235000019515 salmon Nutrition 0.000 description 2
- 235000015067 sauces Nutrition 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- LGQKSQQRKHFMLI-SJYYZXOBSA-N (2s,3r,4s,5r)-2-[(3r,4r,5r,6r)-4,5,6-trihydroxyoxan-3-yl]oxyoxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)OC1 LGQKSQQRKHFMLI-SJYYZXOBSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- VKUYLANQOAKALN-UHFFFAOYSA-N 2-[benzyl-(4-methoxyphenyl)sulfonylamino]-n-hydroxy-4-methylpentanamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N(C(CC(C)C)C(=O)NO)CC1=CC=CC=C1 VKUYLANQOAKALN-UHFFFAOYSA-N 0.000 description 1
- LGQKSQQRKHFMLI-UHFFFAOYSA-N 4-O-beta-D-xylopyranosyl-beta-D-xylopyranose Natural products OC1C(O)C(O)COC1OC1C(O)C(O)C(O)OC1 LGQKSQQRKHFMLI-UHFFFAOYSA-N 0.000 description 1
- GVUGADOWXGKRAE-SRVKXCTJSA-N 4-[[(2s)-1-[[(2s)-1-[[(2s)-1-(4-nitroanilino)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NC1=CC=C([N+]([O-])=O)C=C1 GVUGADOWXGKRAE-SRVKXCTJSA-N 0.000 description 1
- 102100026802 72 kDa type IV collagenase Human genes 0.000 description 1
- 101710151806 72 kDa type IV collagenase Proteins 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000060696 Alpinia speciosa Species 0.000 description 1
- 235000013411 Alpinia speciosa Nutrition 0.000 description 1
- 235000017519 Artemisia princeps Nutrition 0.000 description 1
- 244000065027 Artemisia princeps Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 239000012695 Ce precursor Substances 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 241000252203 Clupea harengus Species 0.000 description 1
- 102000000503 Collagen Type II Human genes 0.000 description 1
- 108010041390 Collagen Type II Proteins 0.000 description 1
- 102000001187 Collagen Type III Human genes 0.000 description 1
- 108010069502 Collagen Type III Proteins 0.000 description 1
- 102100027995 Collagenase 3 Human genes 0.000 description 1
- 108050005238 Collagenase 3 Proteins 0.000 description 1
- 241001149724 Cololabis adocetus Species 0.000 description 1
- 241001301757 Crepidiastrum lanceolatum Species 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 description 1
- SQNRKWHRVIAKLP-UHFFFAOYSA-N D-xylobiose Natural products O=CC(O)C(O)C(CO)OC1OCC(O)C(O)C1O SQNRKWHRVIAKLP-UHFFFAOYSA-N 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000257465 Echinoidea Species 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010026132 Gelatinases Proteins 0.000 description 1
- 102000013382 Gelatinases Human genes 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000193159 Hathewaya histolytica Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 241000102542 Kara Species 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 240000001221 Leucaena esculenta Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 102100031784 Loricrin Human genes 0.000 description 1
- 102100027998 Macrophage metalloelastase Human genes 0.000 description 1
- 101710187853 Macrophage metalloelastase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000219071 Malvaceae Species 0.000 description 1
- 102100030417 Matrilysin Human genes 0.000 description 1
- 108090000855 Matrilysin Proteins 0.000 description 1
- 102000000422 Matrix Metalloproteinase 3 Human genes 0.000 description 1
- 102100030201 Matrix metalloproteinase-15 Human genes 0.000 description 1
- 108090000560 Matrix metalloproteinase-15 Proteins 0.000 description 1
- 102100030200 Matrix metalloproteinase-16 Human genes 0.000 description 1
- 108090000561 Matrix metalloproteinase-16 Proteins 0.000 description 1
- 102100030219 Matrix metalloproteinase-17 Human genes 0.000 description 1
- 108090000585 Matrix metalloproteinase-17 Proteins 0.000 description 1
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 1
- 108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 102100030411 Neutrophil collagenase Human genes 0.000 description 1
- 101710118230 Neutrophil collagenase Proteins 0.000 description 1
- 241000995070 Nirvana Species 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 229940123973 Oxygen scavenger Drugs 0.000 description 1
- 208000005775 Parakeratosis Diseases 0.000 description 1
- 241000237503 Pectinidae Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 240000001679 Psidium guajava Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 description 1
- 244000173853 Sanguisorba officinalis Species 0.000 description 1
- 241000269851 Sarda sarda Species 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 102100030416 Stromelysin-1 Human genes 0.000 description 1
- 101710108790 Stromelysin-1 Proteins 0.000 description 1
- 102100028848 Stromelysin-2 Human genes 0.000 description 1
- 101710108792 Stromelysin-2 Proteins 0.000 description 1
- 102100028847 Stromelysin-3 Human genes 0.000 description 1
- 108050005271 Stromelysin-3 Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000219793 Trifolium Species 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N Trimethylene glycol Natural products OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000019206 astragalus extract Nutrition 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 239000007765 cera alba Substances 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 210000000991 chicken egg Anatomy 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940096422 collagen type i Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 108010006161 conchiolin Proteins 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 235000021438 curry Nutrition 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000002849 elastaseinhibitory effect Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000019514 herring Nutrition 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 235000008446 instant noodles Nutrition 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 102000007236 involucrin Human genes 0.000 description 1
- 108010033564 involucrin Proteins 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 235000015094 jam Nutrition 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 108010079309 loricrin Proteins 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229930194154 rubusside Natural products 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 235000020637 scallop Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000004320 sodium erythorbate Substances 0.000 description 1
- 235000010352 sodium erythorbate Nutrition 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 108091007196 stromelysin Proteins 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000002349 well water Substances 0.000 description 1
- 235000020681 well water Nutrition 0.000 description 1
- 239000008256 whipped cream Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037373 wrinkle formation Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Birds (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 식물 발효 추출물을 함유하는 항노화제, 상기 항노화제를 이용한 피부외용제 및 음식품에 관한 것이다.The present invention relates to an anti-aging agent containing a plant fermentation extract, an external preparation for skin and food and drink using the anti-aging agent.
피부의 표피 및 진피는 표피세포, 피부 섬유아세포, 및 이들의 세포 바깥에 있어 피부구조를 지지하는 콜라겐이나 엘라스틴 등의 세포외 매트릭스에 의해 구성되어 있다. 젊은 피부에 있어서는 이들 피부조직의 상호작용이 항상성을 유지함으로써, 수분유지, 유연성, 탄력성 등이 확보되어, 피부는 외견적으로도 유연함과 윤기가 있어 생기 있는 상태로 유지된다.The epidermis and dermis of the skin is composed of epidermal cells, skin fibroblasts, and extracellular matrices such as collagen and elastin that support the skin structure outside of these cells. In younger skin, the interaction of these skin tissues maintains homeostasis, thereby ensuring moisture retention, flexibility, and elasticity, and the skin remains apparently supple and shiny.
그런데, 자외선(UV-A, UV-B)의 조사, 공기의 현저한 건조, 과도한 피부세정, 과산화수소와의 접촉 등의 외적 인자의 영향이 있거나, 가령(加齡)이 진행되면, 콜라겐이나 엘라스틴 등의 세포외 매트릭스의 생산량이 감소하는 동시에, 가교에 의한 탄력 저하를 일으킨다. 그 결과, 피부는 보습기능과 탄력성이 저하되어, 각질은 이상 박리를 개시하기 때문에, 피부는 유연함과 윤기를 잃어, 거칠어짐, 주름 등의 노화증상을 나타내게 된다.By the way, there are influences of external factors such as irradiation of ultraviolet rays (UV-A, UV-B), remarkable drying of air, excessive skin cleaning, contact with hydrogen peroxide, or, for example, collagen or elastin. Decreases the amount of extracellular matrix produced, and causes elasticity decrease due to crosslinking. As a result, the skin loses its moisturizing function and elasticity, and keratin starts abnormal peeling, so the skin loses its softness and luster, and exhibits aging symptoms such as roughness and wrinkles.
이와 같이 피부의 노화에 수반되는 변화, 즉 주름, 거무칙칙함, 고운 피부감촉의 소실, 탄력성의 저하 등에는, 콜라겐이나 엘라스틴 등의 진피 매트릭스 성분의 감소 내지 변성이 관여하고 있는 것이 알려져 있다. As described above, it is known that reductions or denaturation of dermal matrix components such as collagen and elastin are involved in changes associated with aging of the skin, that is, wrinkles, dullness, loss of fine skin texture and decrease in elasticity.
콜라겐 중에서도 I형 콜라겐은 가장 많이 체내에 포함되는 콜라겐으로, 피부의 진피에도 많이 포함되어, 피부의 단단함을 만들어내는 역할을 하고 있는 것이 알려져 있다. Among collagen, type I collagen is the most collagen contained in the body, and it is known that it is contained in the dermis of skin and plays the role which produces the firmness of skin.
또한, 엘라스타아제는 피부의 진피에 존재하는 엘라스틴의 가수분해효소인데, 엘라스타아제는 자외선 폭로나 노화에 의해 과잉발현하는 경우가 있어, 엘라스타아제에 의해 엘라스틴이 변성·파괴되면, 피부의 탄력성이 저하되는 것으로 생각되고 있다.Elastase is an elastin hydrolase present in the dermis of the skin. Elastase may be overexpressed by UV exposure or aging. When elastin is denatured and destroyed by elastase, It is thought that elasticity falls.
또한, 최근 진피 매트릭스 성분의 감소 내지 변성을 유도하는 인자로서, 매트릭스 메탈로프로테아제류(이하, 「MMPs」라 칭하는 경우도 있다)로 불리는 단백질 분해효소군을 들 수 있다.In addition, a group of protease enzymes called matrix metalloproteases (hereinafter sometimes referred to as "MMPs") can be cited as factors that induce reduction or denaturation of dermal matrix components in recent years.
상기 MMPs는 그 1차 구조와 기질특이성의 차이로부터, (1) 콜라게나제군(MMP-1, MMP-8 및 MMP-13), (2) 젤라티나제군(MMP-2 및 MMP-9), (3) 스트로멜리신군(MMP-3 및 MMP-10), (4) 막결합형 매트릭스 메탈로프로테아제군(MMP-14, MMP-15, MMP-16, 및 MMP-17), (5) 기타(MMP-7, MMP-11, 및 MMP-12)의 5개의 그룹으로 분류되어 있다(일본국 특허공개 제2000-344672호 공보 참조).The MMPs are characterized by (1) collagenase groups (MMP-1, MMP-8 and MMP-13), (2) gelatinase groups (MMP-2 and MMP-9), (3) stromelysin group (MMP-3 and MMP-10), (4) membrane-bound matrix metalloprotease group (MMP-14, MMP-15, MMP-16, and MMP-17), (5) other (MMP-7, MMP-11, and MMP-12) in five groups (see Japanese Patent Laid-Open No. 2000-344672).
상기 MMPs 중에서도 MMP-1 및 MMP-14는, 피부의 진피 매트릭스의 주된 구성성분인 I형 콜라겐, II형 콜라겐, III형 콜라겐을 분해하는 효소로서 알려져 있다. 또한, 그 발현은 자외선의 조사에 의해 크게 증가하고, 자외선에 의한 콜라겐의 감소 내지 변성의 하나의 원인이 되어, 피부의 주름 형성 등의 커다란 요인으로 생각된다.Among the MMPs, MMP-1 and MMP-14 are known as enzymes that decompose type I collagen, type II collagen and type III collagen, which are the main constituents of the dermal matrix of the skin. In addition, the expression is greatly increased by irradiation of ultraviolet rays, which is one of the causes of the reduction or denaturation of collagen caused by ultraviolet rays, and is considered to be a large factor such as wrinkle formation of the skin.
또한, 가령에 수반되는 피부노화의 하나의 원인으로서, 여성 호르몬의 일종인 에스트로겐의 분비가 감퇴하는 것이 있다. 에스트로겐은 성인 여성의 건강유지에 깊이 관여하고 있어, 그 분비부족은 각종 내과적 질환을 초래하는 것 외에, 피부의 과민증, 탄력성 저하, 수분 감소 등의 바람직하지 않은 피부 변화의 원인이 되는 것이 알려져 있다.In addition, as one of the causes of skin aging, for example, the secretion of estrogen, which is a type of female hormone, is reduced. Estrogen is deeply involved in maintaining the health of adult women, and its lack of secretion leads to various medical diseases, and it is known to cause undesirable skin changes such as skin hypersensitivity, decreased elasticity, and reduced moisture. .
또한, 각질층은 표피각화세포가 종말분화되어 형성된 각질세포와, 세포간을 매우는 세포간 지질로 형성된다. 세라마이드를 주성분으로 하는 세포간 지질은 라멜라구조를 형성함으로써, 각질층 배리어기능을 담당하고 있다. 한편, 각질세포는 케라틴 섬유를 주성분으로 하고, 막의 라이닝 단백인 코니파이드 엔벨로프(cornified envelope)(각질비후막, 이하 「CE」라고 약칭한다.)라는 소수적(疏水的)이며 강인한 세포막 유사 구조물에 덮여 있다. CE는 표피각화세포의 분화에 따라 세포 내에서 생산되는 인볼루크린(involucrin), 로리크린(loricrin) 등 복수의 CE 전구체 단백질이 효소 트랜스글루타미나아제-1에 의해 가교되고, 불용화되어 형성되며, 이 CE가 피부의 배리어기능에 밀접하게 관여하고 있다. 또한, 그의 일부에는 세라마이드 등이 공유 결합하여, 소수적인 구조를 취함으로써 세포간 지질의 라멜라구조의 토대를 공급하여, 각질층 배리어기능 및 피부의 수분유지기능의 기초가 형성된다.In addition, the stratum corneum is formed of keratinocytes formed by terminal differentiation of epidermal keratinocytes and intercellular lipids, which are intercellular. Intercellular lipids containing ceramide as a main component are responsible for the stratum corneum barrier function by forming a lamellar structure. Keratin cells, on the other hand, are composed of keratin fibers as a major component and in a hydrophobic and tough cell membrane-like structure called cornified envelope (hereinafter, abbreviated as "CE"), which is a lining protein of membrane. Covered. CE forms a plurality of CE precursor proteins such as involucrin and loricrin, which are produced intracellularly by differentiation of epidermal keratinocytes, by cross-linking and insolubilizing by enzyme transglutaminase-1. This CE is closely involved in the barrier function of the skin. In addition, ceramide and the like are covalently bonded to a part thereof to take a hydrophobic structure, thereby providing a foundation for the lamellar structure of intercellular lipids, thereby forming a foundation of the stratum corneum barrier function and skin moisture retention function.
그러나, 가령, 건조, 자외선(UV-A, UV-B) 등의 영향에 의해 턴오버 속도에 이상이 생기면, 라멜라구조의 흐트러짐이나 CE가 불완전한 상태로 형성된, 이른바 부전각화(不全角化)가 유발되어, 각질세포나 세포간 지질의 구조에 이상이 생겨, 각질층의 수분유지기능 및 배리어기능은 저하된다. 이것이 피부 거칠어짐, 건조 피부 등의 피부의 노화증상으로 연결되는 것으로 생각된다. 또한, 건선이나 아토피성 피부염의 환자의 경우에는, 배리어기능이 저하된 피진부(皮疹部)에서 미숙한 CE가 고빈도로 관찰되어, CE가 바르게 형성되는 것이 피부의 배리어기능에 매우 중요한 것으로 생각되고 있다(Experimental Dermatology 12:591-601(2003) 참조).However, if an abnormality occurs in the turnover speed due to the effects of drying or ultraviolet rays (UV-A, UV-B), for example, the so-called parakeratosis, in which the lamellar structure is disturbed or the CE is incompletely formed. Induced, abnormality in the structure of keratinocytes and intercellular lipids, the water retention function and barrier function of the stratum corneum is reduced. It is thought that this leads to aging symptoms of skin such as rough skin and dry skin. In the case of patients with psoriasis or atopic dermatitis, immature CE is observed at high frequency in the lowered part of the skin where barrier function is reduced, and it is considered that it is very important for the barrier function of the skin. (See Experimental Dermatology 12: 591-601 (2003)).
이와 같은 사실로부터, 피부 섬유아세포 증식 촉진작용, 트랜스글루타미나아제-1 생산 촉진작용, 엘라스타아제 활성 저해작용, MMP-1 활성 저해작용, 에스트로겐 유사 작용, I형 콜라겐 생산 촉진작용, 표피각화세포 증식 촉진작용, UV-B 손상으로부터의 회복작용 등의 각 작용을 갖는 항노화제는, 피부의 탄력성 저하, 거칠어짐, 주름 등의 피부의 노화증상을 효과적으로 예방 내지 개선할 수 있을 것으로 생각된다.From these facts, skin fibroblast proliferation, transglutaminase-1 production, elastase activity inhibition, MMP-1 activity inhibition, estrogen-like action, type I collagen production promotion, epidermal keratinization It is thought that anti-aging agent having each action such as promoting cell proliferation and restoring from UV-B damage can effectively prevent or improve skin aging symptoms such as decreased elasticity, roughness and wrinkles of the skin. .
그러나, 현재까지는 입수가 용이하고 저렴하며, 안전성이 높은 천연물계의 것으로, 맛, 냄새, 사용감 등의 측면에서 첨가 대상물의 품질에 악영향을 미치지 않아, 피부외용제 및 음식품에 널리 사용 가능한 항노화제는 아직 제공되고 있지 않기에, 그 신속한 제공이 강하게 요구되고 있는 것이 현재 상황이다.However, to date, it is an easy-to-use, inexpensive, high-safety natural product, and does not adversely affect the quality of the added object in terms of taste, smell, and usability, and thus is widely used for external skin preparations and food and drink. Has not been provided yet, so the prompt provision is strongly required.
본 발명은 상기 종래에 있어서의 제문제를 해결하고, 이하의 목적을 달성하는 것을 과제로 한다. 즉, 본 발명은 우수한 항노화 작용(피부 섬유아세포 증식 촉진작용, 트랜스글루타미나아제-1 생산 촉진작용, 엘라스타아제 활성 저해작용, MMP-1 활성 저해작용, 에스트로겐 유사 작용, I형 콜라겐 생산 촉진작용, 표피각화세포 증식 촉진작용, UV-B 손상으로부터의 회복작용 등)을 가지며, 또한 안전성이 높은 항노화제, 상기 항노화제를 이용한 피부외용제 및 음식품을 제공하는 것을 목적으로 한다.This invention solves the problem in the said prior art, and makes it a subject to achieve the following objectives. That is, the present invention has excellent anti-aging action (promoting skin fibroblast proliferation, promoting transglutaminase-1 production, inhibiting elastase activity, inhibiting MMP-1 activity, estrogen-like action, type I collagen production) It is aimed to provide an anti-aging agent having high promoting action, promoting epidermal keratinocyte proliferation, restoring from UV-B damage, etc., and a highly safe anti-aging agent, an external preparation for skin and food and drink using the anti-aging agent.
본 발명자 등은 상기 과제를 해결하기 위해 예의 검토를 행한바, 쑥, 버개스, 구아바, 씀바귀, 은자귀나무, 울금, 및 월도의 각 식물을 각각 발효시켜서 얻어지는 각 식물 발효물을 추가적으로 추출함으로써 얻어지는 각 식물 발효 추출물이, 피부 섬유아세포 증식 촉진작용, 트랜스글루타미나아제-1 생산 촉진작용, 엘라스타아제 활성 저해작용, MMP-1 활성 저해작용, 에스트로겐 유사 작용, I형 콜라겐 생산 촉진작용, 표피각화세포 증식 촉진작용, 및 UV-B 손상으로부터의 회복작용 중 적어도 어느 하나를 토대로 하는 우수한 항노화 작용을 갖는 것을 발견하고, 본 발명을 완성하기에 이르렀다.In order to solve the above problems, the present inventors have made intensive studies, and further extract each plant fermentation product obtained by fermenting each plant of mugwort, bagasse, guava, moth, silver bark, turmeric, and woldo, respectively. The obtained plant fermentation extracts promote skin fibroblast proliferation, transglutaminase-1 production, elastase activity inhibition, MMP-1 activity inhibition, estrogen-like activity, type I collagen production promotion, The present invention has been found to have excellent anti-aging action based on at least one of epidermal keratinocyte proliferation promoting action and recovery from UV-B damage.
본 발명은 본 발명자 등의 상기 지견(知見)을 토대로 하는 것으로, 상기 과제를 해결하기 위한 수단으로서는 이하와 같다. 즉,This invention is based on the said knowledge of this inventor, etc., As a means for solving the said subject, it is as follows. In other words,
<1> 발효 쑥의 추출물, 발효 버개스의 추출물, 발효 구아바의 추출물, 발효 씀바귀의 추출물, 발효 은자귀나무의 추출물, 발효 울금의 추출물, 및 발효 월도의 추출물로부터 선택되는 1종 이상을 함유하는 것을 특징으로 하는 항노화제이다.<1> contains at least one selected from extracts of fermented mugwort, extracts of fermented bagus, extracts of fermented guava, extracts of fermented moth, extract of fermented silverwood, extract of fermented turmeric, and extract of fermented moonshine It is an anti-aging agent characterized in that.
<2> 피부 섬유아세포 증식 촉진작용, 트랜스글루타미나아제-1 생산 촉진작용, 엘라스타아제 활성 저해작용, MMP-1 활성 저해작용, 에스트로겐 유사 작용, I형 콜라겐 생산 촉진작용, 표피각화세포 증식 촉진작용, 및 UV-B 손상으로부터의 회복작용 중 적어도 어느 하나를 갖는 상기 <1>에 기재된 항노화제이다.<2> Skin fibroblast proliferation, transglutaminase-1 production promotion, elastase activity inhibition, MMP-1 activity inhibition, estrogen-like action, type I collagen production promotion, epidermal keratinocyte proliferation It is an anti-aging agent as described in said <1> which has at least any of a promoting action and a recovery action from UV-B damage.
<3> 상기 <1>에서 <2> 중 어느 하나에 기재된 항노화제를 함유하는 것을 특징으로 하는 피부외용제이다.<3> A skin external preparation containing the anti-aging agent according to any one of <1> to <2>.
<4> 상기 <1>에서 <2> 중 어느 하나에 기재된 항노화제를 함유하는 것을 특징으로 하는 음식품이다.<4> Food and drink characterized by containing the anti-aging agent in any one of said <1> to <2>.
본 발명에 의하면, 종래에 있어서의 제문제를 해결하고, 상기 목적을 달성할 수 있으며, 우수한 항노화 작용(피부 섬유아세포 증식 촉진작용, 트랜스글루타미나아제-1 생산 촉진작용, 엘라스타아제 활성 저해작용, MMP-1 활성 저해작용, 에스트로겐 유사 작용, I형 콜라겐 생산 촉진작용, 표피각화세포 증식 촉진작용, UV-B 손상으로부터의 회복작용 등)을 가지며, 또한 안전성이 높은 항노화제, 상기 항노화제를 이용한 피부외용제 및 음식품을 제공할 수 있다.ADVANTAGE OF THE INVENTION According to this invention, it is possible to solve the problem in the prior art and to achieve the above object, and to have excellent anti-aging action (promoting skin fibroblast proliferation, transglutaminase-1 production promoting action, elastase activity). Inhibition, MMP-1 activity inhibition, estrogen-like action, type I collagen production promotion, epidermal keratinocyte proliferation, recovery from UV-B damage, etc.) The external preparation for skin and food and drink using an anti-aging agent can be provided.
본 발명의 항노화제, 피부외용제 및 음식품은 일상적으로 사용하는 것이 가능하고, 유효성분인 상기 각 식물 발효 추출물의 작용에 의해서, 피부 섬유아세포 증식 촉진작용, 트랜스글루타미나아제-1 생산 촉진작용, 엘라스타아제 활성 저해작용, MMP-1 활성 저해작용, 에스트로겐 유사 작용, I형 콜라겐 생산 촉진작용, 표피각화세포 증식 촉진작용, 및 UV-B 손상으로부터의 회복작용 중 적어도 어느 하나를 토대로 하는 항노화 작용을 매우 효과적으로 발휘시킬 수 있는 것이다. 이 때문에, 본 발명의 항노화제, 피부외용제 및 음식품에 의하면, 피부의 탄력성 저하, 거칠어짐, 주름 등의 피부 노화증상의 예방·개선을 효과적을 행할 수 있게 되는 것이 기대된다.The anti-aging agent, external preparation for skin and food and drink of the present invention can be used on a daily basis, and by the action of each of the above-mentioned plant fermentation extracts as active ingredients, it promotes skin fibroblast proliferation and transglutaminase-1 production. Based on at least one of elastase inhibitory activity, MMP-1 activity inhibitory, estrogen-like activity, type I collagen production promotion, epidermal keratinocyte proliferation, and recovery from UV-B damage Aging can be very effective. For this reason, according to the anti-aging agent, the external preparation for skin, and the food-drinks of this invention, it is anticipated that the prevention and improvement of skin aging symptoms, such as skin elasticity fall, roughness, and wrinkles, can be performed effectively.
또한, 본 발명의 항노화제, 피부외용제 및 음식품은 인간에 대해 적합하게 적용되는 것이지만, 그 작용효과가 나타내어지는 한, 인간 이외의 동물(예를 들면, 마우스, 랫트, 햄스터, 개, 고양이, 소, 돼지, 원숭이 등)에 대해 적용하는 것도 가능하다. 또한, 본 발명의 항노화제, 피부외용제 및 음식품은 천연 유래의 각 식물 발효 추출물을 유효성분으로 한 것으로, 안전성이 우수한 측면에서도 유리하다.In addition, although the anti-aging agent, the external preparation for skin, and the food-drinks of this invention are suitably applied to a human, as long as the effect is exhibited, animals other than humans (for example, a mouse, a rat, a hamster, a dog, a cat, Cattle, pigs, monkeys, etc.). In addition, the anti-aging agent, the external preparation for skin, and the food and drink of the present invention are made from natural plant-derived fermented extracts as active ingredients, and are also advantageous in terms of excellent safety.
(항노화제)(Anti-aging agent)
본 발명의 항노화제는 발효 쑥의 추출물, 발효 버개스의 추출물, 발효 구아바의 추출물, 발효 씀바귀의 추출물, 발효 은자귀나무의 추출물, 발효 울금의 추출물, 및 발효 월도의 추출물로부터 선택되는 1종 이상을 함유해서 되고, 추가적으로 필요에 따라서 기타 성분을 함유해서 된다.The anti-aging agent of the present invention is selected from the extract of fermented mugwort, the extract of fermented bagasse, the extract of fermented guava, the extract of fermented moth, the extract of fermented silverwood, the extract of fermented turmeric, and the extract of fermented woldo It may contain species or more, and may contain other components as necessary.
여기서, 상기 발효 쑥의 추출물, 발효 버개스의 추출물, 발효 구아바의 추출물, 발효 씀바귀의 추출물, 발효 은자귀나무의 추출물, 발효 울금의 추출물, 및 발효 월도의 추출물이란, 각각 쑥, 버개스, 구아바, 씀바귀, 은자귀나무, 울금, 및 월도의 각 식물을 각각 발효시켜서 얻어지는 발효물(본 명세서 중에서, 「식물 발효물」이라 칭하는 경우가 있다)을 추가적으로 추출함으로써 얻어지는 추출물(본 명세서 중에서, 「식물 발효 추출물」이라 칭하는 경우가 있다)을 말한다.Here, the extract of the fermented mugwort extract, the extract of fermented bagus, the extract of fermented guava, the extract of fermented moth, the extract of fermented silverwood, the extract of fermented turmeric, and the extract of fermented moonshine, respectively, mugwort, bagasse, Extract obtained by additionally extracting a fermentation product (sometimes referred to as "plant fermentation product" in the present specification) obtained by fermenting each plant of guava, nirvana, herbarium, turmeric, and woldo (in this specification, The term "plant fermentation extract" may be referred to).
상기 항노화제는 피부 섬유아세포 증식 촉진작용, 트랜스글루타미나아제-1 생산 촉진작용, 엘라스타아제 활성 저해작용, MMP-1 활성 저해작용, 에스트로겐 유사 작용, I형 콜라겐 생산 촉진작용, 표피각화세포 증식 촉진작용, 및 UV-B 손상으로부터의 회복작용 중 적어도 어느 하나를 토대로 하는 항노화 작용을 갖는 것이다. The anti-aging agent promotes skin fibroblast growth, transglutaminase-1 production, elastase activity inhibition, MMP-1 activity inhibition, estrogen-like action, type I collagen production promotion, epidermal keratinization It has an anti-aging action based on at least one of a cell proliferation promoting action and a recovery action from UV-B damage.
상기 발효 쑥의 추출물, 발효 버개스의 추출물, 발효 구아바의 추출물, 발효 씀바귀의 추출물, 발효 은자귀나무의 추출물, 발효 울금의 추출물, 및 발효 월도의 추출물에 있어서의 항노화 작용을 발휘하는 물질의 상세에 대해서는 불명확하지만, 상기 각 식물 발효 추출물이 이와 같은 우수한 작용을 가져, 항노화제로서 유용한 사실은 종래에는 전혀 알려져 있지 않고, 본 발명자 등에 의한 새로운 지견이다.Substances exhibiting anti-aging activity in the extract of the fermented mugwort, the extract of fermented bagasse, the extract of fermented guava, the extract of fermented moth, the extract of fermented silverwood, the extract of fermented turmeric, and the extract of fermented moonshine Although it is unclear about the detail of the above, the fact that each said plant fermentation extract has such an excellent effect and is useful as an anti-aging agent is not known at all, and it is a new knowledge by this inventor.
상기 쑥은 국화과의 식물로서, 학명은 Artemisia princeps이다. 상기 쑥은 다년초로, 일본 전국에 널리 분포되어 있어, 이들의 지역으로부터 용이하게 입수 가능하다.The wormwood is a plant of the Asteraceae, the scientific name is Artemisia princeps . The wormwood is perennial, widely distributed throughout Japan, and can be easily obtained from these areas.
발효원료로서 사용하는 상기 쑥의 부위로서는 특별히 제한은 없고, 목적에 따라서 적절히 선택할 수 있으나, 예를 들면 꽃, 봉오리, 과실, 과피, 종자, 종피, 줄기, 잎, 가지, 지엽, 나무줄기, 수피, 뿌리, 뿌리줄기, 근피, 이들의 혼합물 등을 들 수 있고, 이들 중에서도 잎, 줄기가 바람직하다.There is no restriction | limiting in particular as a site | part of the said mugwort used as a fermentation raw material, Although it can select suitably according to the objective, For example, a flower, a bud, a fruit, a peel, a seed, a seedling, a stem, a leaf, a branch, a branch leaf, a tree trunk, a bark , Roots, rhizomes, rhizomes, mixtures thereof, and the like, of which leaves and stems are preferred.
상기 버개스(bagasse)란, 사탕수수(학명: Saccharum officinarum)로부터 설탕을 제조하는 과정에서 발생하는 사탕수수의 압착 찌꺼기이다. 이 때문에, 상기 버개스는 사탕수수로부터 설탕을 제조할 때의 폐기물로서 용이하게 입수 가능하다.The bagasse is a squeezing dreg of sugarcane generated in the process of preparing sugar from sugarcane ( Saccharum officinarum ). For this reason, the said bagus can be easily obtained as a waste at the time of manufacturing sugar from sugar cane.
발효원료로서 사용하는 상기 버개스로서는 특별히 제한은 없고, 목적에 따라서 적절히 선택할 수 있으며, 예를 들면 생 버개스, 건조 버개스 등을 들 수 있고, 이들 중에서도 건조 버개스가 바람직하다.There is no restriction | limiting in particular as said bagus used as a fermentation raw material, According to the objective, it can select suitably, For example, a raw baggar, a dry baggar, etc. are mentioned, Among these, dry baggar is preferable.
상기 구아바는 도금양과의 식물로서, 학명은 Psidium guajava Linn이다. 상기 구아바는 상록수로, 동남아시아, 중국 남부, 하와이 등의 열대, 아열대지역에 널리 분포하고 있어, 이들의 지역으로부터 용이하게 입수 가능하다.The guava is a Platinum family, scientific name is Psidium guajava Linn. The guava is evergreen, widely distributed in tropical and subtropical regions such as Southeast Asia, South China, Hawaii, and can be easily obtained from these regions.
발효원료로서 사용하는 상기 구아바의 부위로서는 특별히 제한은 없고, 목적에 따라서 적절히 선택할 수 있으나, 예를 들면 꽃, 봉오리, 과실, 과피, 종자, 종피, 줄기, 잎, 가지, 지엽, 나무줄기, 수피, 뿌리, 뿌리줄기, 근피, 이들의 혼합물 등을 들 수 있고, 이들 중에서도 잎이 바람직하다.There is no restriction | limiting in particular as a site | part of the said guava used as a fermentation raw material, Although it can select suitably according to the objective, For example, a flower, a bud, a fruit, a peel, a seed, a seed, a stem, a leaf, a branch, a branch, a tree trunk, a bark , Roots, rhizomes, rhizomes, mixtures thereof, and the like, among which leaves are preferred.
상기 씀바귀는 국화과의 식물로서, 학명은 Crepidiastrum lanceolatum Nakai이다. 상기 씀바귀는 다년초로, 오키나와 등, 일본의 산지나 들판에 널리 식생·분포하고 있어, 이들의 지역으로부터 용이하게 입수 가능하다.The moth is a plant of the family Asteraceae, scientific name is Crepidiastrum lanceolatum Nakai. The above-mentioned moth is a perennial plant, which is widely vegetated and distributed in mountains and fields of Japan, such as Okinawa, and can be easily obtained from these areas.
발효원료로서 사용하는 상기 씀바귀의 부위로서는 특별히 제한은 없고, 목적에 따라서 적절히 선택할 수 있으나, 예를 들면 꽃, 봉오리, 과실, 과피, 종자, 종피, 줄기, 잎, 가지, 지엽, 나무줄기, 수피, 뿌리, 뿌리줄기, 근피, 이들의 혼합물 등을 들 수 있고, 이들 중에서도 잎이 바람직하다.There is no restriction | limiting in particular as a site | part of the said bark used as a fermentation raw material, Although it can select suitably according to the objective, For example, a flower, a bud, fruit, a peel, a seed, a seed, a stem, a leaf, a branch, a branch, a tree trunk, a bark , Roots, rhizomes, rhizomes, mixtures thereof, and the like, among which leaves are preferred.
상기 은자귀나무는 콩과의 식물로서, 학명은 Leucaena leucocephala이다. 상기 은자귀나무는 다년성 식물로서, 열대, 아열대지방에 널리 분포하고 있으며, 또한 일본에서는 오키나와지방에서도 재배되고 있어, 이들의 지역으로부터 용이하게 입수 가능하다.The herbaceous tree is a legume plant, scientific name is Leucaena leucocephala . The herbaceous tree is a perennial plant, widely distributed in the tropics and subtropics, and is also cultivated in Okinawa in Japan, and can be easily obtained from these areas.
발효원료로서 사용하는 상기 은자귀나무의 부위로서는 특별히 제한은 없고, 목적에 따라서 적절히 선택할 수 있으나, 예를 들면 꽃, 봉오리, 과실, 과피, 종자, 종피, 줄기, 잎, 가지, 지엽, 나무줄기, 수피, 뿌리, 뿌리줄기, 근피, 이들의 혼합물 등을 들 수 있고, 이들 중에서도 잎, 줄기가 바람직하다.There is no restriction | limiting in particular as a site | part of the said silverwood tree used as a fermentation raw material, Although it can select suitably according to the objective, For example, a flower, a bud, fruit, a rind, a seed, a seed, a stem, a leaf, a branch, a branch, a tree trunk , Bark, root, rhizome, root bark, and mixtures thereof. Among these, leaves and stems are preferable.
상기 울금은 생강과의 식물로서, 학명은 Curcuma longa L.이다. 상기 울금은 다년초로, 인도, 동남아시아, 중국 남부 등의 열대지방이나 일본에서는 오키나와지방에서도 재배되고 있어, 이들의 지역으로부터 용이하게 입수 가능하다.The turmeric is a plant of the family Ginger, scientific name is Curcuma longa L. The turmeric is a perennial plant and is cultivated in the tropical regions of India, Southeast Asia, southern China, and even in Okinawa in Japan, and can be easily obtained from these regions.
발효원료로서 사용하는 상기 울금의 부위로서는 특별히 제한은 없고, 목적에 따라서 적절히 선택할 수 있으나, 예를 들면 꽃, 봉오리, 과실, 과피, 종자, 종피, 줄기, 잎, 가지, 지엽, 나무줄기, 수피, 뿌리, 뿌리줄기, 근피, 이들의 혼합물 등을 들 수 있고, 이들 중에서도 뿌리줄기가 바람직하다.There is no restriction | limiting in particular as a site | part of the said turmeric used as a fermentation raw material, Although it can select suitably according to the objective, For example, a flower, a bud, a fruit, a peel, a seed, a seedling, a stem, a leaf, a branch, a branch leaf, a tree trunk, a bark , Roots, rhizomes, rhizomes, mixtures thereof, and the like, among which rhizomes are preferred.
상기 월도는 생강과의 식물로서, 학명은 Alpinia speciosa K. Schum이다. 상기 월도는 다년초로, 규슈 남부에서 중국 남부~열대 아시아에 널리 분포하고 있어, 이들의 지역으로부터 용이하게 입수 가능하다.Woldo is a plant of the family Ginger, scientific name is Alpinia speciosa K. Schum. The moon is perennial, widely distributed from southern Kyushu to southern China to tropical Asia, and can be easily obtained from these regions.
발효원료로서 사용하는 상기 월도의 부위로서는 특별히 제한은 없고, 목적에 따라서 적절히 선택할 수 있으나, 예를 들면 꽃, 봉오리, 과실, 과피, 종자, 종피, 줄기, 잎, 가지, 지엽, 나무줄기, 수피, 뿌리, 뿌리줄기, 근피, 이들의 혼합물 등을 들 수 있고, 이들 중에서도 잎이 바람직하다.There is no restriction | limiting in particular as said site | part of the said woldo used as a fermentation raw material, Although it can select suitably according to the objective, For example, a flower, a bud, a fruit, a peel, a seed, a seedling, a stem, a leaf, a branch, a branch leaf, a tree trunk, Bark, root, rhizome, root bark, mixtures thereof and the like, among which leaves are preferred.
상기 각 식물은 각 식물 발효물을 얻기 위한 발효원료로서 사용된다. 상기 각 식물을 임의의 방법으로 발효시킴으로써, 각 식물 발효물을 얻을 수 있다. 상기 각 식물의 발효방법으로서는 특별히 제한은 없고, 목적에 따라서 적절히 선택할 수 있으나, 예를 들면 일본국 특허공개 제2004-267100호 공보(쑥), 일본국 특허 제4031637호 공보(쑥, 구아바, 월도), 일본국 특허 제4067805호(버개스), 일본국 특허공개 제2006-347985호 공보(씀바귀), 일본국 특허 제2596472호 공보(은자귀나무), 일본국 특허 제2949411호(울금), 일본국 특허공개 제2004-345986호 공보(울금), 일본국 특허공개 제2007-99625호 공보(월도)에 기재된 방법 등을 적합하게 채용할 수 있다. 구체적으로는, 예를 들면 상기 각 식물을 건조한 후, 그대로의 상태로 또는 조쇄기(粗碎機) 등을 사용하여 분쇄한 상태로, 유산균, 효모, 고초균 등의 미생물에 의한 발효처리에 제공함으로써, 상기 각 식물 발효물을 얻을 수 있다.Each plant is used as a fermentation raw material for obtaining each plant fermentation product. By fermenting each said plant by arbitrary methods, each plant fermentation product can be obtained. There is no restriction | limiting in particular as a fermentation method of each said plant, Although it can select suitably according to the objective, For example, Unexamined-Japanese-Patent No. 2004-267100 (mugwort), Unexamined-Japanese-Patent No. 4031637 (mugwort, guava, walnut) Japanese Patent No. 4067805 (Burgas), Japanese Patent Laid-Open No. 2006-347985 (Cursor), Japanese Patent No. 2596472 (Silverwood), Japanese Patent No. 2949411 (Golden) And the method described in Japanese Patent Application Laid-Open No. 2004-345986 (Purple), Japanese Patent Application Laid-Open No. 2007-99625 (Mondo), and the like can be suitably employed. Specifically, for example, by drying each of the above-mentioned plants in the state as it is, or in a state in which the plants are ground using a crushing machine or the like, they are subjected to fermentation treatment by microorganisms such as lactic acid bacteria, yeast, Bacillus subtilis and the like. Each plant fermentation product can be obtained.
상기와 같이 하여 얻어진 각 식물 발효물은 각 식물 발효 추출물을 얻기 위한 추출원료로서 사용된다. 상기 각 식물 발효물은, 예를 들면 건조한 후, 용매 추출에 제공할 수 있다. 상기 건조는, 예를 들면 햇볕에서 행해도 되고, 통상 사용되는 건조기를 사용하여 행해도 된다. 또한, 상기 각 식물 발효물은 멸균처리를 실시한 후, 추출원료로서 사용해도 된다. 상기 멸균처리는, 예를 들면 가열 등의 공지의 방법으로 행할 수 있다. 또한, 상기 각 식물 발효물은 헥산, 벤젠 등의 비극성용매에 의해서 탈지 등의 전처리를 실시한 후, 추출원료로서 사용해도 된다. 탈지 등의 전처리를 행함으로써, 상기 각 식물 발효물의 극성용매에 의한 추출처리를 효율적으로 행할 수 있다.Each plant fermentation product obtained as mentioned above is used as an extraction raw material for obtaining each plant fermentation extract. Each plant fermentation product may be, for example, dried and then used for solvent extraction. The said drying may be performed in the sun, for example, and may be performed using the dryer normally used. In addition, each said plant fermentation product may be used as an extraction raw material after carrying out sterilization treatment. The said sterilization process can be performed by well-known methods, such as heating, for example. In addition, each said plant fermentation product may be used as an extraction raw material after carrying out pretreatment, such as degreasing with a nonpolar solvent, such as hexane and benzene. By performing pretreatment, such as degreasing, the extraction process by the polar solvent of each said plant fermentation product can be performed efficiently.
상기 각 식물 발효 추출물은 식물의 추출에 일반적으로 사용되는 방법을 이용하여, 상기 식물 발효물에 추출처리를 실시함으로써, 용이하게 얻을 수 있다. 또한, 상기 각 식물 발효 추출물로서는 시판품을 사용해도 된다. 또한, 상기 각 식물 발효 추출물에는 상기 각 식물 발효물의 추출액, 이 추출액의 희석액 또는 농축액, 이 추출액의 건조물, 또는 이들의 조정제물 또는 정제물 모두가 포함된다.Each plant fermentation extract can be easily obtained by subjecting the plant fermentation to an extraction process using a method generally used for extraction of plants. Moreover, you may use a commercial item as said each plant fermentation extract. In addition, each plant fermentation extract includes an extract of each plant fermentation, a diluent or concentrate of the extract, a dried product of the extract, or a crude or purified product thereof.
상기 추출에 사용하는 용매로서는 특별히 제한은 없고, 목적에 따라서 적절히 선택할 수 있으며, 예를 들면 물, 친수성 유기용매, 또는 이들의 혼합용매를, 실온 또는 용매의 비점 이하의 온도에서 사용하는 것이 바람직하다. 상기 각 식물 발효물에 포함되는 항노화 작용을 나타내는 성분은, 극성용매를 추출용매로 하는 추출처리에 의해서 용이하게 추출할 수 있다.There is no restriction | limiting in particular as a solvent used for the said extraction, According to the objective, it can select suitably, For example, it is preferable to use water, a hydrophilic organic solvent, or these mixed solvents at room temperature or the temperature below the boiling point of a solvent. . The component which exhibits the anti-aging effect contained in each said plant fermentation product can be extracted easily by the extraction process which uses a polar solvent as an extraction solvent.
상기 추출용매로서 사용할 수 있는 물로서는 특별히 제한은 없고, 목적에 따라서 적절히 선택할 수 있으며, 예를 들면 순수, 수돗물, 우물물, 광천수, 광수(鑛水), 온천수, 용수(湧水), 담수 등 외에, 이들에 각종 처리를 실시한 것이 포함된다. 물에 실시하는 처리로서는, 예를 들면 정제, 가열, 살균, 여과, 이온 교환, 침투압의 조정, 완충화 등이 포함된다. 따라서, 상기 추출용매로서 사용할 수 있는 물에는 정제수, 열수, 이온 교환수, 생리식염수, 인산완충액, 인산완충 생리식염수 등도 포함된다.There is no restriction | limiting in particular as water which can be used as the said extraction solvent, According to the objective, it can select suitably, For example, pure water, tap water, well water, mineral water, mineral water, hot spring water, spring water, fresh water, etc. And those subjected to various treatments are included. The treatment to water includes, for example, purification, heating, sterilization, filtration, ion exchange, adjustment of penetration pressure, buffering, and the like. Accordingly, water that can be used as the extraction solvent includes purified water, hot water, ion exchange water, physiological saline, phosphate buffer, phosphate buffered saline, and the like.
상기 추출용매로서 사용할 수 있는 친수성 유기용매로서는 특별히 제한은 없고, 목적에 따라서 적절히 선택할 수 있으며, 예를 들면 메탄올, 에탄올, 프로필알코올, 이소프로필알코올 등의 탄소수 1~5의 저급 알코올; 아세톤, 메틸에틸케톤 등의 저급 지방족 케톤; 1,3-부틸렌글리콜, 프로필렌글리콜, 글리세린 등의 탄소수 2~5의 다가 알코올 등을 들 수 있고, 이 친수성 유기용매와 물의 혼합용매 등도 사용할 수 있다. 또한, 상기 물과 상기 친수성 유기용매의 혼합용매를 사용할 때에는 저급 알코올의 경우는 물 10 질량부에 대해 1~90 질량부, 저급 지방족 케톤의 경우는 물 10 질량부에 대해 1~40 질량부를 혼합한 것을 사용하는 것이 바람직하다. 또한, 다가 알코올의 경우는 물 10 질량부에 대해 1~90 질량부를 혼합한 것을 사용하는 것이 바람직하다.There is no restriction | limiting in particular as a hydrophilic organic solvent which can be used as said extraction solvent, According to the objective, it can select suitably, For example, C1-C5 lower alcohols, such as methanol, ethanol, propyl alcohol, isopropyl alcohol; Lower aliphatic ketones such as acetone and methyl ethyl ketone; C2-C5 polyhydric alcohols, such as 1, 3- butylene glycol, propylene glycol, and glycerin, These mixed solvents of a hydrophilic organic solvent and water, etc. can also be used. When using a mixed solvent of the water and the hydrophilic organic solvent, 1 to 90 parts by mass with respect to 10 parts by mass of water for lower alcohols, and 1 to 40 parts by mass with respect to 10 parts by mass of water of lower aliphatic ketones. It is preferable to use one. In addition, in the case of a polyhydric alcohol, it is preferable to use what mixed 1-90 mass parts with respect to 10 mass parts of water.
또한, 발효 월도를 추출원료로 하는 경우, 이들의 용매 중에서도 피부 섬유아세포 증식 촉진작용, 트랜스글루타미나아제-1 생산 촉진작용, MMP-1 활성 저해작용, UV-B 손상으로부터의 회복작용 등을 높일 수 있는 측면에서, 저급 알코올을 물 10 질량부에 대해 5~20 질량부 혼합한 혼합용매를 사용하는 것이 바람직하다.In addition, when fermentation month is used as an extraction material, among these solvents, skin fibroblast proliferation promoting effect, transglutaminase-1 production promoting effect, MMP-1 activity inhibitory effect, recovery from UV-B damage, etc. It is preferable to use the mixed solvent which mixed 5-20 mass parts of lower alcohols with respect to 10 mass parts of water from the point which can raise the.
추출원료인 상기 각 식물 발효물로부터 항노화 작용을 갖는 추출물을 추출함에 있어서, 특수한 추출방법을 채용할 필요는 없고, 실온 또는 환류가열하에서 임의의 추출장치를 사용하여 추출할 수 있다.In extracting an extract having an anti-aging action from each of the above-mentioned plant fermentation products, it is not necessary to employ a special extraction method, and may be extracted using any extraction apparatus at room temperature or under reflux heating.
구체적으로는, 추출용매를 가득 채운 처리조 내에, 상기 각 추출원료를 투입하고, 추가적으로 필요에 따라서 때때로 교반하면서, 30분간~4시간 정치(靜置)하여 가용성 성분을 용출한 후, 여과하여 고형물을 제거하고, 얻어진 추출액으로부터 추출용매를 증류 제거하여, 건조함으로써 추출물을 얻을 수 있다. 추출 용매량은 통상 추출원료의 5~15배량(질량비)이다. 추출조건은 추출용매로서 물을 사용한 경우에는 통상 50~95℃에서 1~4시간 정도이다. 또한, 추출용매로서 물과 에탄올의 혼합용매를 사용한 경우에는 통상 40~95℃에서 30분간~4시간 정도이다. 또한, 용매로 추출함으로써 얻어지는 추출액은 추출용매가 안전성이 높은 것이면, 그대로 본 발명의 항노화제의 유효성분으로서 사용할 수 있다.Specifically, each of the above-mentioned extraction raw materials is added to a treatment tank filled with an extraction solvent, and the mixture is left still for 30 minutes to 4 hours while occasionally stirring as necessary, eluting the soluble components, and then filtering and solids. The extract can be obtained by removing the residue, distilling and extracting the extraction solvent from the obtained extract. The extraction solvent amount is usually 5 to 15 times (mass ratio) of the extraction raw material. Extraction conditions are usually about 1 to 4 hours at 50 to 95 ° C when water is used as the extraction solvent. In addition, when the mixed solvent of water and ethanol is used as an extraction solvent, it is about 30 minutes-about 4 hours at 40-95 degreeC normally. The extract obtained by extraction with a solvent can be used as it is as an active ingredient of the anti-aging agent of the present invention as long as the extraction solvent has high safety.
추출에 의해 얻어지는 상기 각 식물 발효물의 추출액은, 이 추출액의 희석액 또는 농축액, 이 추출액의 건조물, 또는 이들의 조정제물 또는 정제물을 얻기 위해, 통상적인 방법에 따라서 희석, 농축, 건조, 정제 등의 처리를 실시해도 된다. 또한, 얻어지는 상기 각 식물 발효물의 추출액은 그대로도 항노화제의 유효성분으로서 사용할 수 있지만, 농축액 또는 그의 건조물로 한 것이 이용하기 쉽다. 추출액의 건조물을 얻음에 있어서는 통상적인 방법을 이용할 수 있고, 또한 흡습성을 개선하기 위해 덱스트린, 시클로덱스트린 등의 캐리어를 첨가해도 된다. 또한, 추출원료인 상기 각 식물 발효물은 특유의 냄새와 맛을 가지고 있는 경우가 있어, 이 때문에 상기 각 식물 발효물의 추출물에 대해서는 생리활성의 저하를 초래하지 않는 범위에서, 탈색, 탈취 등을 목적으로 하는 정제를 행하는 것도 가능하지만, 예를 들면 피부 화장료에 첨가하는 경우 등에는 대량으로 사용하는 것은 아니기 때문에, 미정제 그대로도 실용상 지장은 없다. 또한, 정제는 구체적으로는 활성탄처리, 흡착 수지처리, 이온교환 수지처리 등에 의해서 행할 수 있다.The extracts of the above-mentioned plant fermentation products obtained by extraction may be diluted, concentrated, dried or purified according to a conventional method in order to obtain a diluted or concentrated liquid of the extract, a dried product of the extract, or a crude or purified product thereof. You may perform a process. Moreover, although the extract liquid of each said plant fermentation obtained can be used as an active ingredient of an anti-aging agent as it is, it is easy to use what was used as the concentrated liquid or its dried product. In obtaining the dried material of an extract, a conventional method can be used, and in order to improve hygroscopicity, you may add carriers, such as dextrin and cyclodextrin. In addition, the above-mentioned plant fermented product, which is an extract raw material, may have a peculiar smell and taste. Therefore, the extract of each plant fermented product may be decolorized, deodorized, etc. in a range that does not cause a decrease in physiological activity. Although refinement | purification to be made is possible, for example, when adding to skin cosmetics, since it is not used in large quantities, even unrefined raw material does not interfere practically. In addition, the purification can be performed specifically by activated carbon treatment, adsorption resin treatment, ion exchange resin treatment or the like.
이상과 같이 하여 얻어지는 상기 각 식물 발효물의 추출물(식물 발효 추출물)은 피부 섬유아세포 증식 촉진작용, 트랜스글루타미나아제-1 생산 촉진작용, 엘라스타아제 활성 저해작용, MMP-1 활성 저해작용, 에스트로겐 유사 작용, I형 콜라겐 생산 촉진작용, 표피각화세포 증식 촉진작용, 및 UV-B 손상으로부터의 회복작용 중 적어도 어느 하나를 가져, 이들의 작용을 토대로, 본 발명의 항노화제의 유효성분으로서 적합하게 이용 가능한 것이다. 또한, 상기 식물 발효 추출물은 상기한 각 작용을 토대로, 피부 섬유아세포 증식 촉진제, 트랜스글루타미나아제-1 생산 촉진제, 엘라스타아제 활성 저해제, MMP-1 활성 저해제, 에스트로겐 유사 작용제, I형 콜라겐 생산 촉진제, 표피각화세포 증식 촉진제, UV-B 손상으로부터의 회복작용제로서도 각각 적합하게 이용 가능하다.The extract of each plant fermentation product (plant fermentation extract) obtained as described above is effective for promoting skin fibroblast proliferation, promoting transglutaminase-1 production, inhibiting elastase activity, inhibiting MMP-1 activity, estrogen It has at least one of similar action, type I collagen production promoting action, epidermal keratinocyte proliferation promoting action, and recovery from UV-B damage, and is suitable as an active ingredient of the anti-aging agent of the present invention based on these actions. Is available. In addition, the plant fermentation extract is based on the above-described action, the skin fibroblast proliferation promoter, transglutaminase-1 production promoter, elastase activity inhibitor, MMP-1 activity inhibitor, estrogen-like agent, type I collagen production It can be suitably used also as an accelerator, an epidermal keratinocyte proliferation promoter, and a recovery agent from UV-B damage.
상기 항노화제 중의 상기 각 식물 발효 추출물의 함유량으로서는 특별히 제한은 없고, 목적에 따라서 적절히 선택할 수 있으며, 또한 상기 항노화제는 상기 각 식물 발효 추출물 그 자체여도 된다.There is no restriction | limiting in particular as content of the said plant fermentation extract in the said anti-aging agent, According to the objective, it can select suitably, Moreover, the said anti-aging agent may be said each plant fermentation extract itself.
또한, 상기 항노화제 중, 상기 각 식물 발효 추출물은 어느 1종만 포함되어 있어도 되고, 2종 이상이 포함되어 있어도 된다. 상기 항노화제 중에 2종 이상의 식물 발효 추출물이 포함되는 경우의 각각의 함유량비로서도 특별히 제한은 없고, 목적에 따라서 적절히 선택할 수 있다.Moreover, any 1 type of said each plant fermentation extract may be contained in the said anti-aging agent, and 2 or more types may be contained. There is no restriction | limiting in particular also as each content ratio in the case where 2 or more types of plant fermentation extracts are contained in the said anti-aging agent, According to the objective, it can select suitably.
또한, 상기 항노화제 중에 포함될 수 있는 상기 각 식물 발효 추출물 이외의 기타 성분으로서도, 본 발명의 효과를 손상시키지 않는 범위내이면 특별히 제한은 없고, 목적에 따라서 적절히 선택할 수 있으며, 예를 들면 상기 각 식물 발효 추출물을 목적하는 농도로 희석 등을 하기 위한 생리식염액 등을 들 수 있다. 또한, 상기 항노화제 중의 상기 기타 성분의 함유량에도 특별히 제한은 없고, 목적에 따라서 적절히 선택할 수 있다.The other components other than the above-mentioned plant fermentation extracts which may be included in the anti-aging agent are not particularly limited as long as they are within the range that does not impair the effects of the present invention, and may be appropriately selected according to the purpose. And a physiological saline solution for diluting the plant fermentation extract to a desired concentration. Moreover, there is no restriction | limiting in particular also in content of the said other component in the said anti-aging agent, According to the objective, it can select suitably.
또한, 상기 항노화제는 필요에 따라서 제제화함으로써, 분말상, 과립상, 정제상 등 임의의 제형으로 할 수 있다.In addition, the said anti-aging agent can be formulated as needed, and can be made into arbitrary formulations, such as powder form, a granule form, and a tablet form.
본 발명의 항노화제는 피부 섬유아세포 증식 촉진작용, 트랜스글루타미나아제-1 생산 촉진작용, 엘라스타아제 활성 저해작용, MMP-1 활성 저해작용, 에스트로겐 유사 작용, I형 콜라겐 생산 촉진작용, 표피각화세포 증식 촉진작용, 및 UV-B 손상으로부터의 회복작용 중 적어도 어느 하나를 토대로 하는 우수한 항노화 작용을 갖는 동시에, 안전성이 우수하기 때문에, 예를 들면 후술하는 본 발명의 피부외용제, 본 발명의 음식품 등으로의 이용에 적합하다.The anti-aging agent of the present invention promotes skin fibroblast proliferation, transglutaminase-1 production, elastase activity inhibition, MMP-1 activity inhibition, estrogen-like action, type I collagen production promotion, In addition to having excellent anti-aging action based on at least one of epidermal keratinocyte proliferation promoting action and recovery from UV-B damage, and excellent in safety, the external preparation for skin of the present invention described below, for example, It is suitable for use as food and drink.
(피부외용제)(Skin external preparation)
본 발명의 피부외용제는 상기한 본 발명의 항노화제를 함유해서 되고, 추가적으로 필요에 따라서 기타 성분을 함유해서 된다.The external preparation for skin of the present invention contains the anti-aging agent of the present invention described above, and may further contain other components as necessary.
여기서, 상기 피부외용제란, 피부에 적용되는 각종 약제를 의미하고, 그 구분으로서는 특별히 제한되는 것은 아니며, 예를 들면 피부 화장료, 의약부외품, 의약품 등을 폭 넓게 포함하는 것이다.Here, the external skin preparation means various drugs applied to the skin, and the distinction is not particularly limited, and includes, for example, skin cosmetics, quasi-drugs, and medicines widely.
상기 피부외용제는 상기 각 식물 발효 추출물을 그 활성을 방해하지 않도록 임의의 피부외용제에 배합한 것이어도 되고, 상기 각 식물 발효 추출물을 주성분으로 한 피부외용제여도 된다. 또한, 상기 피부외용제는 상기 각 식물 발효 추출물 그 자체여도 된다.The said external skin agent may be mix | blended with each skin external preparation, so that the said plant fermentation extract may not interfere with the activity, and the external skin preparation which has said each plant fermentation extract as a main component may be sufficient as it. In addition, the said skin external preparation may be said each plant fermentation extract itself.
상기 피부외용제로서는 특별히 제한은 없고, 목적에 따라서 적절히 선택할 수 있으며, 예를 들면 연고, 크림, 유액, 미용액, 로션, 팩, 파운데이션, 립크림, 입욕제, 헤어토닉, 헤어로션, 비누, 바디샴푸 등을 들 수 있다.There is no restriction | limiting in particular as said skin external preparation, According to the objective, it can select suitably, For example, ointment, cream, emulsion, beauty liquid, lotion, pack, foundation, lip cream, bath agent, hair tonic, hair lotion, soap, body shampoo, etc. Can be mentioned.
상기 기타 성분으로서는 특별히 제한은 없고, 목적에 따라서 적절히 선택할 수 있으며, 피부외용제를 제조함에 있어서 통상 사용되는 성분, 예를 들면 수렴제, 살균, 항균제, 미백제, 자외선흡수제, 보습제, 세포 부활제, 항노화제, 소염·항알레르기제, 항산화·활성산소 제거제, 유지류, 왁스류, 탄화수소류, 지방산류, 알코올류, 에스테르류, 계면활성제, 향료 등을 들 수 있다.There is no restriction | limiting in particular as said other components, According to the objective, it can select suitably, The components normally used in manufacture of a skin external preparation, for example, astringent, antiseptic, antibacterial agent, whitening agent, ultraviolet absorber, moisturizer, cell activator, anti-aging Agents, anti-inflammatory and anti-allergic agents, antioxidants and active oxygen scavengers, fats and oils, waxes, hydrocarbons, fatty acids, alcohols, esters, surfactants, and fragrances.
상기 피부외용제 중의 상기 항노화제의 함유량으로서는 특별히 제한은 없고, 피부외용제의 종류 등에 따라서 적절히 선택할 수 있으나, 예를 들면 상기 각 식물 발효 추출물의 양으로서 0.0001~10 질량%가 바람직하고, 0.001~5 질량%가 보다 바람직하다.There is no restriction | limiting in particular as content of the said anti-aging agent in the said external skin agent, Although it can select suitably according to the kind of external skin agent etc., For example, 0.0001-10 mass% is preferable as the quantity of each said plant fermentation extract, 0.001-5 Mass% is more preferable.
(음식품)(Beverage food)
본 발명의 음식품은 상기한 본 발명의 항노화제를 함유해서 되고, 추가적으로 필요에 따라서 기타 성분을 함유해서 된다.The food-drinks of this invention contain the anti-aging agent of this invention mentioned above, and also contain other components as needed.
여기서, 상기 음식품이란, 인간의 건강에 위해를 가할 우려가 적고, 통상의 사회생활에 있어서 경구 또는 소화관 투여에 의해 섭취되는 것을 말하며, 행정구분상의 식품, 의약품, 의약부외품 등의 구분에 제한되는 것은 아니며, 예를 들면 경구적으로 섭취되는 일반식품, 건강식품, 보건기능식품, 의약부외품, 의약품 등을 폭 넓게 포함하는 것을 의미한다.Here, the food and drink means that there is little risk of harm to human health and is ingested by oral or digestive tract administration in normal social life, and is limited to the division of food, medicine, quasi-drug, etc. in administrative division. It does not mean, for example, it means to include a general food, health food, health functional food, quasi-drugs, pharmaceuticals and the like ingested orally widely.
상기 음식품은 상기 각 식물 발효 추출물을 그 활성을 방해하지 않도록 임의의 음식물에 배합한 것이어도 되고, 상기 각 식물 발효 추출물을 주성분으로 하는 영양보조식품이어도 된다. 또한, 상기 음식품은 상기 각 식물 발효 추출물 그 자체여도 된다.The food or drink may be formulated with any food or drink so as not to interfere with the activity of the respective plant fermentation extracts, or may be a dietary supplement containing the respective plant fermentation extracts as a main component. In addition, the said food-drinks may be said each plant fermentation extract itself.
상기 음식품으로서는 특별히 제한은 없고, 목적에 따라서 적절히 선택할 수 있으며, 예를 들면, 청량음료, 탄산음료, 영양음료, 과실음료, 유산음료 등의 음료; 아이스크림, 아이스 셔벗, 빙수 등의 냉과(冷菓); 메밀국수, 가락국수, 당면, 만두피, 찐만두피, 중화면, 즉석면 등의 면류; 엿, 캔디, 껌, 초콜릿, 정과(錠菓), 스낵과자, 비스킷, 젤리, 잼, 크림, 구운과자, 빵 등의 과자류; 게, 연어, 모시조개, 참치, 정어리, 새우, 가다랑어, 고등어, 고래, 굴, 꽁치, 오징어, 피조개, 가리비, 전복, 성게, 연어알, 떡조개 등의 수산물; 어묵, 햄, 소시지 등의 수산·축산 가공식품; 가공유, 발효유 등의 유제품; 샐러드유, 튀김유, 마가린, 마요네즈, 쇼트닝, 휘핑크림, 드레싱 등의 유지 및 유지 가공식품; 소스, 조미 국물 등의 조미료; 카레, 스튜, 닭고기 계란 덮밥, 쌀죽(粥), 채소나 어패류 등을 잘게 썰어 넣고 된장이나 간장으로 간을 맞추어 끓인 죽(雜炊), 중화 덮밥, 돈가스 덮밥, 튀김 덮밥, 장어 덮밥, 하이라이스, 어묵탕, 마파두부, 소고기 덮밥, 미트소스, 계란스프, 오므라이스, 만두, 찐만두, 햄버그, 미트볼 등의 레토르트 파우치 식품; 각종 형태의 건강식품이나 영양보조식품; 정제, 캡슐제, 드링크제, 트로키 등의 의약품, 의약부외품 등을 들 수 있다.There is no restriction | limiting in particular as said food-drinks, According to the objective, it can select suitably, For example, drinks, such as a soft drink, a carbonated drink, a nutritional drink, an fruit drink, a lactic acid drink; Frozen desserts such as ice cream, ice sherbet, and ice water; Noodles such as soba (buckwheat noodles), kara noodles, vermicelli, dumplings, steamed dumplings, medium noodles, and instant noodles; Confectionery such as candy, candy, gum, chocolate, sweets, snacks, biscuits, jelly, jam, cream, baked sweets and bread; Aquatic products, such as crab, salmon, clam, tuna, sardine, shrimp, bonito, mackerel, whale, oyster, saury, squid, shellfish, scallops, abalone, sea urchin, salmon roe, rice cake clam; Fish and livestock processed foods such as fish paste, ham and sausage; Dairy products such as processed milk and fermented milk; Fat and oil processed foods such as salad oil, fried oil, margarine, mayonnaise, shortening, whipped cream and dressing; Seasonings such as sauces and seasonings; Finely chopped curry, stew, chicken egg rice bowl, rice porridge, vegetables or seafood and seasoned with miso or soy sauce Retort pouch foods such as tang, mapo tofu, beef bowl, meat sauce, egg soup, omelet rice, dumplings, steamed dumplings, hamburg, meatballs; Health foods and nutritional supplements in various forms; Medicines such as tablets, capsules, drinks, troches, quasi drugs, and the like.
상기 기타 성분으로서는 특별히 제한은 없고, 목적에 따라서 적절히 선택할 수 있으며, 예를 들면 음식품을 제조함에 있어서 통상 사용되는 보조적 원료 또는 첨가물 등을 들 수 있다.There is no restriction | limiting in particular as said other components, According to the objective, it can select suitably, For example, the auxiliary raw material or additives normally used in manufacturing food-drinks are mentioned.
상기 보조적 원료 또는 첨가물로서는 특별히 제한은 없고, 목적에 따라서 적절히 선택할 수 있으며, 예를 들면 포도당, 과당, 자당, 말토오스, 소르비톨, 스테비오사이드, 루부소사이드, 콘 시럽, 젖당, 구연산, 타르타르산, 사과산, 숙신산, 젖산, L-아스코르브산, dl-α-토코페롤, 에리소르빈산나트륨, 글리세린, 프로필렌글리콜, 글리세린 지방산 에스테르, 폴리글리세린 지방산 에스테르, 자당 지방산 에스테르, 소르비탄 지방산 에스테르, 아라비아검, 카라기난, 카세인, 젤라틴, 펙틴, 한천, 비타민 B류, 니코틴산아미드, 판토텐산칼슘, 아미노산류, 칼슘염류, 색소, 향료, 보존제 등을 들 수 있다.There is no restriction | limiting in particular as said auxiliary raw material or additive, According to the objective, it can select suitably, For example, glucose, fructose, sucrose, maltose, sorbitol, stevioside, rubus side, corn syrup, lactose, citric acid, tartaric acid, malic acid, Succinic acid, lactic acid, L-ascorbic acid, dl-α-tocopherol, sodium erythorbate, glycerin, propylene glycol, glycerin fatty acid ester, polyglycerin fatty acid ester, sucrose fatty acid ester, sorbitan fatty acid ester, gum arabic, carrageenan, casein, gelatin , Pectin, agar, vitamin B, nicotinic acid amide, calcium pantothenate, amino acids, calcium salts, pigments, flavorings, preservatives and the like.
상기 음식품 중의 상기 항노화제의 함유량으로서는 대상이 되는 음식품의 종류에 따라서 상이하여 일률적으로는 규정할 수 없으나, 예를 들면 음식품 본래의 맛을 손상시키지 않는 범위에서 임의의 음식물에 배합하는 것을 목적으로 하는 경우에는, 유효성분인 상기 각 식물 발효 추출물의 양으로서 0.001 질량%~50 질량%가 바람직하고, 0.01 질량%~20 질량%가 보다 바람직하다. 또한, 예를 들면 상기 각 식물 발효 추출물을 주성분으로 하는 과립, 정제, 캡슐형태 등의 영양보조 음식품을 제조하는 것을 목적으로 하는 경우에는, 유효성분인 상기 각 식물 발효 추출물의 양으로서 0.01 질량%~100 질량%가 바람직하고, 5 질량%~100 질량%가 보다 바람직하다.The content of the anti-aging agent in the food and drink is different depending on the type of food and drink to be targeted and cannot be regulated uniformly. For example, the anti-aging agent is formulated into any food and drink within a range that does not impair the original taste of the food and drink. When it aims at that, 0.001 mass%-50 mass% are preferable, and, as for the quantity of each said plant fermentation extract which is an active ingredient, 0.01 mass%-20 mass% are more preferable. In addition, for example, in the case of manufacturing a dietary supplement such as granules, tablets, capsules, etc., each of which has the respective plant fermentation extracts as a main component, it is 0.01% by mass as the amount of each plant fermentation extract which is an active ingredient. 100 mass% is preferable and 5 mass%-100 mass% are more preferable.
[실시예]EXAMPLE
이하 본 발명의 실시예를 설명하지만, 본 발명은 이들의 실시예에 조금도 한정되는 것은 아니다.Hereinafter, although the Example of this invention is described, this invention is not limited to these Examples at all.
(제조예 1)(Manufacture example 1)
-각 식물 발효물의 물추출물의 제조-Production of Water Extracts of Each Plant Fermentation
추출원료가 되는 식물 발효물로서, 발효 쑥, 발효 버개스, 발효 구아바, 발효 씀바귀, 발효 은자귀나무, 발효 울금, 및 발효 월도(모두 가부시키가이샤 류큐 바이오 리소스 가이하쓰제)를 각각 사용하였다. 상기 각 식물 발효물 100 g을 물 1,000 ㎖에 투입하고, 온화하게 교반하면서 2시간, 90℃로 유지한 후, 여과하였다. 여액을 40℃에서 감압하에 농축하고, 추가적으로 감압건조기로 건조하여, 분말상의 추출물을 얻었다. 얻어진 추출물(식물 발효 추출물)의 수율을 표 1에 나타낸다.As a plant fermentation product to be extracted, fermented mugwort, fermented bagasse, fermented guava, fermented moth, fermented herb, fermented turmeric, and fermented Woldo (all are manufactured by Ryukyu Bio-Resource Kaihatsu). . 100 g of each plant fermented product was added to 1,000 ml of water, and maintained at 90 ° C. for 2 hours with gentle stirring, followed by filtration. The filtrate was concentrated under reduced pressure at 40 ° C. and further dried with a vacuum dryer to obtain a powdery extract. The yield of the obtained extract (plant fermentation extract) is shown in Table 1.
(제조예 2)(Manufacture example 2)
-각 식물 발효물의 50 질량% 에탄올 추출물의 제조-Preparation of 50% by Mass Ethanol Extract of Each Plant Ferment
추출원료가 되는 식물 발효물로서, 발효 쑥, 발효 버개스, 발효 구아바, 발효 씀바귀, 발효 은자귀나무, 발효 울금, 및 발효 월도(모두 가부시키가이샤 류큐 바이오 리소스 가이하쓰제)를 각각 사용하였다. 상기 각 식물 발효물 100 g을 50 질량% 에탄올(물과 에탄올의 질량비 1:1) 1,000 ㎖에 투입하고, 온화하게 교반하면서 2시간, 90℃로 유지한 후, 여과하였다. 여액을 40℃에서 감압하에 농축하고, 추가적으로 감압건조기로 건조하여, 분말상의 추출물을 얻었다. 얻어진 추출물(식물 발효 추출물)의 수율을 표 1에 나타낸다.As a plant fermentation product to be extracted, fermented mugwort, fermented bagasse, fermented guava, fermented moth, fermented herb, fermented turmeric, and fermented Woldo (all are manufactured by Ryukyu Bio-Resource Kaihatsu). . 100 g of each plant fermented product was added to 1,000 ml of 50 mass% ethanol (mass ratio of water and ethanol 1: 1), the mixture was kept at 90 ° C. for 2 hours with gentle stirring, and then filtered. The filtrate was concentrated under reduced pressure at 40 ° C. and further dried with a vacuum dryer to obtain a powdery extract. The yield of the obtained extract (plant fermentation extract) is shown in Table 1.
(제조예 3)(Manufacture example 3)
-각 식물 발효물의 80 질량% 에탄올 추출물의 제조-Preparation of 80 Mass% Ethanol Extract of Each Plant Fermentation
추출원료가 되는 식물 발효물로서, 발효 쑥, 발효 버개스, 발효 구아바, 발효 씀바귀, 발효 은자귀나무, 발효 울금, 및 발효 월도(모두 가부시키가이샤 류큐 바이오 리소스 가이하쓰제)를 각각 사용하였다. 상기 각 식물 발효물 100 g을 80 질량% 에탄올(물과 에탄올의 질량비 1:4) 1,000 ㎖에 투입하고, 온화하게 교반하면서 2시간, 90℃로 유지한 후, 여과하였다. 여액을 40℃에서 감압하에 농축하고, 추가적으로 감압건조기로 건조하여, 분말상의 추출물을 얻었다. 얻어진 추출물(식물 발효 추출물)의 수율을 표 1에 나타낸다.As a plant fermentation product to be extracted, fermented mugwort, fermented bagasse, fermented guava, fermented moth, fermented herb, fermented turmeric, and fermented Woldo (all are manufactured by Ryukyu Bio-Resource Kaihatsu). . 100 g of each plant fermented product was added to 1,000 ml of 80 mass% ethanol (mass ratio of water and ethanol 1: 4), and the mixture was kept at 90 ° C. for 2 hours with gentle stirring, followed by filtration. The filtrate was concentrated under reduced pressure at 40 ° C. and further dried with a vacuum dryer to obtain a powdery extract. The yield of the obtained extract (plant fermentation extract) is shown in Table 1.
(실시예 1: 피부 섬유아세포 증식 촉진작용 시험)Example 1 Skin Fibroblast Proliferation Promotion Test
상기 각 식물 발효 추출물을 피험시료로서 사용하여, 하기의 시험방법으로 피부 섬유아세포 증식 촉진작용을 시험하였다.Using each plant fermented extract as a test sample, the skin fibroblast proliferation promoting effect was tested by the following test method.
인간 정상 피부 섬유아세포(NB1RGB)를 10% FBS 함유 α-MEM을 사용하여 배양한 후, 트립신처리에 의해 세포를 회수하였다. 회수한 세포를 7.0×104 cells/mL의 농도로 5% FBS 함유 α-MEM으로 희석한 후, 96 웰 플레이트(well plate)에 1 웰당 100 μL씩 파종하고, 하룻밤 배양하였다. 배양종료 후, 5% FBS 함유 α-MEM으로 용해한 피험시료를 각 웰에 100 μL 첨가하고, 3일간 배양하였다. 피부 섬유아세포 증식 촉진작용은 MTT 어세이법을 사용하여 측정하였다. 배양종료 후, 각 웰로부터 100 μL씩 배지를 빼고, 종농도 5 ㎎/mL로 PBS(-)에 용해한 MTT를 각 웰에 20 μL씩 첨가하였다. 4.5시간 배양한 후, 10% SDS를 용해한 0.01 ㏖/L 염산용액을 각 웰에 100 μL씩 첨가하고, 하룻밤 배양한 후, 파장 570 ㎚에 있어서의 흡광도를 측정하였다. 동시에 탁도로서 파장 650 ㎚에 있어서의 흡광도를 측정하고, 양자의 차를 블루 포르마잔 생성량으로 하였다. 또한, 동일한 방법으로 공시험을 행하여 보정하였다.Human normal dermal fibroblasts (NB1RGB) were cultured using α-MEM containing 10% FBS, and then cells were recovered by trypsinization. The recovered cells were diluted with α-MEM containing 5% FBS at a concentration of 7.0 × 10 4 cells / mL, and then seeded in a well of a 96 well plate at 100 μL per well and incubated overnight. After the completion of the culture, 100 μL of the test sample dissolved in α-MEM containing 5% FBS was added to each well and incubated for 3 days. Dermal fibroblast proliferation was measured using the MTT assay. After incubation, 100 μL of the medium was removed from each well, and 20 μL of MTT dissolved in PBS (−) at a final concentration of 5 mg / mL was added to each well. After incubation for 4.5 hours, 100 μL of 0.01 mol / L hydrochloric acid solution in which 10% SDS was dissolved was added to each well, followed by incubation overnight, and the absorbance at wavelength 570 nm was measured. At the same time, the absorbance at a wavelength of 650 nm was measured as turbidity, and the difference between them was defined as the amount of blue formazan produced. In addition, a blank test was carried out in the same manner and corrected.
피부 섬유아세포 증식 촉진작용의 계산방법은 이하와 같다. 결과를 표 2~7에 나타낸다. The calculation method of the skin fibroblast proliferation promoting action is as follows. The results are shown in Tables 2-7.
피부 섬유아세포 증식 촉진율(%) = (St-Sb)/(Ct-Cb)×100Skin fibroblast growth rate (%) = (St-Sb) / (Ct-Cb) × 100
St: 피험시료를 첨가한 세포에서의 흡광도St: Absorbance in Cells Added Test Samples
Sb: 피험시료를 첨가한 공시험의 흡광도Sb: absorbance of blank test with test sample
Ct: 피험시료를 첨가하지 않는 세포에서의 흡광도Ct: absorbance in cells without addition of test sample
Cb: 피험시료를 첨가하지 않는 공시험의 흡광도Cb: absorbance of blank test without addition of test sample
(실시예 2: 트랜스글루타미나아제-1 생산 촉진작용 시험)Example 2: Transglutaminase-1 Production Promoting Test
상기 각 식물 발효 추출물을 피험시료로서 사용하여, 하기의 시험방법으로 트랜스글루타미나아제-1 생산 촉진작용을 시험하였다.Using each plant fermented extract as a test sample, the transglutaminase-1 production promoting action was tested by the following test method.
인간 정상 신생아 피부 표피각화세포(NHEK)를 인간 정상 신생아 표피각화세포용 배지(KGM)를 사용하여 배양한 후, 트립신처리에 의해 세포를 회수하였다. 회수한 세포를 1×105 cells/mL의 농도가 되도록 KGM으로 희석한 후, 96 웰 플레이트에 1 웰당 100 μL씩 파종하고, 2일간 배양하였다. 배양종료 후, KGM으로 용해한 피험시료를 각 웰에 100 μL 첨가하고, 24시간 배양하였다. 배양종료 후, 배지를 빼고, 세포를 플레이트에 고정시켜, 세포 표면에 발현된 트랜스글루타미나아제-1의 양을 단일클론 항인간 트랜스글루타미나아제-1 항체를 사용한 ELISA법으로 측정하였다.Human normal neonatal skin epidermal keratinocytes (NHEK) were cultured using human normal neonatal epidermal keratinocyte medium (KGM), and then cells were recovered by trypsinization. The collected cells were diluted with KGM so as to have a concentration of 1 × 10 5 cells / mL, and then seeded in a 96 well plate at 100 μL per well, and cultured for 2 days. After the end of the culture, 100 μL of the test sample dissolved in KGM was added to each well, and cultured for 24 hours. After the end of the culture, the medium was removed, the cells were fixed to the plate, and the amount of transglutaminase-1 expressed on the cell surface was measured by ELISA using monoclonal antihuman transglutaminase-1 antibody.
트랜스글루타미나아제-1 생산 촉진작용의 계산방법은 이하와 같다. 결과를 표 8~12에 나타낸다.The calculation method of the transglutaminase-1 production promoting action is as follows. The results are shown in Tables 8-12.
트랜스글루타미나아제-1 생산 촉진율(%) = A/B×100Transglutaminase-1 Production Promotion Rate (%) = A / B × 100
A: 피험시료 첨가시의 파장 405 ㎚에 있어서의 흡광도A: absorbance at wavelength 405 nm at the time of test sample addition
B: 피험시료 무첨가시(대조)의 파장 405 ㎚에 있어서의 흡광도B: absorbance at a wavelength of 405 nm when no test sample was added (control)
(실시예 3: 엘라스타아제 활성 저해작용 시험)Example 3: Elastase Activity Inhibition Test
상기 각 식물 발효 추출물을 피험시료로서 사용하여, 하기의 시험방법으로 엘라스타아제 활성 저해작용을 시험하였다.Using each plant fermented extract as a test sample, the elastase activity inhibitory effect was tested by the following test method.
96 웰 플레이트에서 0.2 ㏖/L Tris-HCL 완충액(pH 8.0)으로 조제한 피험시료 50 μL 및 20 ㎍/mL 엘라스타아제·타입 III 용액 50 μL를 혼합하였다. 그 후, 상기 완충액으로 조제한 0.4514 ㎎/mL N-SUCCINYL-ALA-ALA-ALA-p-NITROANILIDE 100 μL를 첨가하고, 25℃에서 15분 반응시켰다. 반응종료 후, 파장 415 ㎚에 있어서의 흡광도를 측정하였다. 동일한 방법으로 공시험을 행하여 보정하였다.In a 96 well plate, 50 μL of the test sample prepared with 0.2 mol / L Tris-HCL buffer (pH 8.0) and 50 μL of the 20 μg / mL elastase type III solution were mixed. Thereafter, 100 µL of 0.4514 mg / mL N-SUCCINYL-ALA-ALA-ALA-p-NITROANILIDE prepared with the above buffer was added and reacted at 25 ° C for 15 minutes. After completion of the reaction, the absorbance at wavelength 415 nm was measured. A blank test was performed in the same manner to correct.
엘라스타아제 활성 저해작용의 계산방법은 이하와 같다. 결과를 표 13~14에 나타낸다.The calculation method of the elastase activity inhibitory effect is as follows. The results are shown in Tables 13-14.
엘라스타아제 활성 저해율(%) = {1-(C-D)/(A-B)}×100% Inhibition of elastase activity = {1- (C-D) / (A-B)} × 100
A: 피험시료 무첨가, 효소 첨가에서의 파장 415 ㎚에 있어서의 흡광도A: Absorption at wavelength 415 nm with no sample added and enzyme addition
B: 피험시료 무첨가, 효소 무첨가에서의 파장 415 ㎚에 있어서의 흡광도B: Absorbance at a wavelength of 415 nm with no test sample and no enzyme
C: 피험시료 첨가, 효소 첨가에서의 파장 415 ㎚에 있어서의 흡광도C: Absorbance at wavelength 415 nm at the addition of test sample and addition of enzyme
D: 피험시료 첨가, 효소 무첨가에서의 파장 415 ㎚에 있어서의 흡광도D: Absorbance at wavelength 415 nm at the addition of test sample and no enzyme
(실시예 4: MMP-1 활성 저해작용 시험)Example 4: MMP-1 activity inhibition test
상기 각 식물 발효 추출물을 피험시료로서 사용하여, 하기의 시험방법으로 MMP-1 활성 저해작용을 시험하였다.Each plant fermented extract was used as a test sample, and the inhibitory effect of MMP-1 activity was tested by the following test method.
시험방법으로서는 Wunsch and Heidrich법을 일부 개변한 방법을 사용하였다. 즉, 뚜껑 부착 시험관에서 20 m㏖/mL 염화칼슘 함유 0.1 ㏖/L Tris-HCl 완충액(pH 7.1)에 용해한 피험시료 50 μL, MMP-1(COLLAGENASE Type IV from Clostridium histolyticum(Sigma사)) 용액 50 μL, 및 Pz-peptide(Pz-Pro-Leu-Gly-Pro-D-Arg-OH(BACHEM Feinchemikalien AG사)) 용액 400 μL를 혼합하고, 37℃에서 30분 반응시킨 후, 25 m㏖/L 구연산 용액 1 mL를 첨가하여 반응을 정지하였다. 그 후, 초산에틸 5 mL를 첨가하여 격렬하게 진탕하였다. 이것을 원심(1,600×g, 10분)하고, 초산에틸층의 파장 320 ㎚에 있어서의 흡광도를 측정하였다. 동일한 방법으로 공시험을 행하여 보정하였다. As a test method, a partly modified Wunsch and Heidrich method was used. That is, 50 μL of the sample dissolved in 20 mmol / mL calcium chloride-containing 0.1 mol / L Tris-HCl buffer (pH 7.1) and 50 μL of MMP-1 (COLLAGENASE Type IV from Clostridium histolyticum (Sigma)) solution in a test tube with a lid , And 400 μL of Pz-peptide (Pz-Pro-Leu-Gly-Pro-D-Arg-OH (BACHEM Feinchemikalien AG)) solution were mixed and reacted at 37 ° C. for 30 minutes, followed by 25 mmol / L citric acid. The reaction was stopped by addition of 1 mL of solution. Thereafter, 5 mL of ethyl acetate was added thereto, followed by vigorous shaking. This was centrifuged (1,600 * g, 10 minutes), and the absorbance in wavelength 320nm of an ethyl acetate layer was measured. A blank test was performed in the same manner to correct.
MMP-1 활성 저해작용의 계산방법은 이하와 같다. 결과를 표 15~19에 나타낸다.The calculation method of MMP-1 activity inhibitory activity is as follows. The results are shown in Tables 15 to 19.
MMP-1 활성 저해율(%) = {1-(C-D)/(A-B)}×100% Inhibition of MMP-1 activity = {1- (C-D) / (A-B)} × 100
A: 피험시료 무첨가, 효소 첨가에서의 파장 320 ㎚에 있어서의 흡광도A: Absorption at wavelength 320nm without addition of test sample and addition of enzyme
B: 피험시료 무첨가, 효소 무첨가에서의 파장 320 ㎚에 있어서의 흡광도B: Absorbance at a wavelength of 320 nm with no test sample and no enzyme
C: 피험시료 첨가, 효소 첨가에서의 파장 320 ㎚에 있어서의 흡광도C: absorbance at wavelength 320 nm at the addition of test sample and addition of enzyme
D: 피험시료 첨가, 효소 무첨가에서의 파장 320 ㎚에 있어서의 흡광도D: Absorbance at wavelength 320 nm at the addition of test sample and no enzyme
(실시예 5: 에스트로겐 유사 작용 시험)Example 5: Estrogen-like Action Test
상기 각 식물 발효 추출물을 피험시료로서 사용하여, 하기의 시험방법에 의해 에스트로겐 유사 작용을 시험하였다.Using each plant fermented extract as a test sample, the estrogen-like action was tested by the following test method.
인간 유방암 유래 세포(MCF-7)를 10% FBS, 1% NEAA, 및 1 m㏖/L 피루브산나트륨을 함유하는 MEM을 사용하여 배양한 후, 트립신처리에 의해 세포를 회수하였다. 회수한 세포를 활성탄처리한 10% FBS, 1% NEAA, 및 1 m㏖/L 피루브산나트륨을 함유하는 페놀 레드 불함유 MEM(T-MEM)을 사용하여 3.0×104 cells/mL의 농도로 희석한 후, 48 웰 플레이트에 1 웰당 450 μL씩 파종하고, 세포를 정착시키기 위해 배양하였다. 6시간 후(0일째)에 T-MEM으로 종농도의 10배로 조제한 피험시료를 각 웰에 50 μL 첨가하여 배양을 계속하였다. 3일째에 배지를 빼고, T-MEM으로 종농도로 조제한 피험시료를 각 웰에 0.5 mL 첨가하여, 추가적으로 배양을 계속하였다. 에스트로겐 유사 작용은 MTT 어세이를 사용하여 측정하였다. 배양종료 후, 배지를 빼고, 1% NEAA, 1 m㏖/L 피루브산나트륨을 함유하는 MEM에 종농도 0.4 ㎎/mL로 용해한 MTT를 각 웰에 200 μL씩 첨가하였다. 2시간 배양한 후, 세포 내에 생성된 블루 포르마잔을 2-프로판올 200 μL로 추출하였다. 추출 후, 파장 570 ㎚에 있어서의 흡광도를 측정하였다. 동시에 탁도로서 파장 650 ㎚에 있어서의 흡광도를 측정하여, 양자의 차를 블루 포르마잔 생성량으로 하였다. 양성 대조로서 1×10-9M 에스트라디올을 사용하였다.Human breast cancer derived cells (MCF-7) were cultured using MEM containing 10% FBS, 1% NEAA, and 1 mmol / L sodium pyruvate, and then cells were recovered by trypsinization. The recovered cells were diluted to a concentration of 3.0 × 10 4 cells / mL using phenol red-free MEM (T-MEM) containing 10% FBS, 1% NEAA, and 1 mmol / L sodium pyruvate treated with activated carbon. Thereafter, 450 μL per well was seeded in 48 well plates and cultured to settle the cells. After 6 hours (day 0), 50 μL of the test sample prepared at 10 times the final concentration by T-MEM was added to each well to continue the culture. On day 3, the medium was removed, and 0.5 mL of the test sample prepared in T-MEM at the final concentration was added to each well, and the culture was further continued. Estrogen-like action was measured using an MTT assay. After the end of the culture, the medium was removed, and 200 μL of MTT dissolved in a well concentration of 0.4 mg / mL in MEM containing 1% NEAA and 1 mmol / L sodium pyruvate was added to each well. After incubation for 2 hours, the blue formazan produced in the cells was extracted with 200 μL of 2-propanol. After extraction, the absorbance at wavelength 570 nm was measured. At the same time, the absorbance at a wavelength of 650 nm was measured as turbidity, and the difference between them was defined as the amount of blue formazan produced. 1 × 10 −9 M estradiol was used as a positive control.
에스트로겐 유사 작용의 계산방법은 이하와 같다. 결과를 표 20~24에 나타낸다.The calculation method of the estrogen-like action is as follows. The results are shown in Tables 20 to 24.
에스트로겐 유사 작용률(%) = A/B×100% Estrogen-like action = A / B × 100
A: 피험시료 첨가시의 흡광도A: absorbance at the time of addition of the test sample
B: 피험시료 무첨가시의 흡광도B: Absorbance when No Sample Added
(실시예 6: I형 콜라겐 생산 촉진작용 시험)Example 6 Type I Collagen Production Promoting Test
상기 각 식물 발효 추출물을 피험시료로서 사용하여, 하기의 시험방법으로 I형 콜라겐 생산 촉진작용을 시험하였다.Using each plant fermented extract as a test sample, the type I collagen production promoting action was tested by the following test method.
인간 정상 섬유아세포(NB1RGB)를 10% FBS 함유 둘베코 MEM을 사용하여 배양한 후, 트립신처리에 의해 세포를 회수하였다. 회수한 세포를 1.6×105 cells/mL의 농도로 상기 배지로 희석한 후, 96 웰 마이크로 플레이트에 1 웰당 100 μL씩 파종하고, 하룻밤 배양하였다. 배양종료 후, 배지를 빼고, 0.25% FBS 함유 둘베코 MEM에 용해한 피험시료를 각 웰에 150 μL 첨가하고, 3일간 배양하였다. 배양 후, 각 웰의 배지 중의 I형 콜라겐량을 ELISA법으로 측정하였다.Human normal fibroblasts (NB1RGB) were incubated with Dulbecco's MEM containing 10% FBS, and then cells were harvested by trypsinization. The collected cells were diluted with the medium at a concentration of 1.6 × 10 5 cells / mL, and then seeded in a 96 well microplate at 100 μL per well and incubated overnight. After the end of the culture, the medium was removed, and 150 μL of the test sample dissolved in Dulbecco's MEM containing 0.25% FBS was added to each well, and cultured for 3 days. After incubation, the amount of type I collagen in the medium of each well was measured by ELISA.
I형 콜라겐 생산 촉진작용의 계산방법은 이하와 같다. 결과를 표 25~29에 나타낸다.The calculation method of the type I collagen production promoting action is as follows. The results are shown in Tables 25 to 29.
I형 콜라겐 생산 촉진율(%) = A/B×100Type I collagen production promotion rate (%) = A / B × 100
A: 피험시료 첨가시의 I형 콜라겐량A: amount of collagen type I when the test sample is added
B: 피험시료 무첨가시의 I형 콜라겐량B: Type I collagen content when no test sample was added
(실시예 7: 표피각화세포 증식 촉진작용 시험)Example 7: Epidermal keratinocyte proliferation promoting test
상기 각 식물 발효 추출물을 피험시료로서 사용하여, 하기의 시험방법으로 표피각화세포 증식 촉진작용을 시험하였다.Each plant fermented extract was used as a test sample, and the epidermal keratinocyte proliferation promoting effect was tested by the following test method.
정상 인간 신생아 포피 표피각화세포(NHEK)를 정상 인간 표피각화세포 장기 배양용 증식배지(EpiLife-KG2)를 사용하여 배양한 후, 트립신처리에 의해 세포를 회수하였다. 회수한 세포를 1.5×104 cells/mL(발효 씀바귀, 발효 울금의 경우) 또는 2.0×104 cells/mL(발효 월도의 경우)의 농도로 EpiLife-KG2로 희석한 후, 콜라겐 코팅한 96 웰 플레이트에 1 웰당 100 μL씩 파종하고, 하룻밤 배양하였다. 배양종료 후, EpiLife-KG2로 용해한 피험시료를 각 웰에 100 μL 첨가하여, 3일간 배양하였다. 표피각화세포 증식 촉진작용은 MTT 어세이법을 사용하여 측정하였다. 배양종료 후, 배지를 빼고, 종농도 0.4 ㎎/mL로 PBS(-)에 용해한 MTT를 각 웰에 100 μL씩 첨가하였다. 2시간 배양한 후, 세포 내에 생성된 블루 포르마잔을 2-프로판올 100 μL로 추출하였다. 추출 후, 파장 570 ㎚에 있어서의 흡광도를 측정하였다. 동시에 탁도로서 파장 650 ㎚에 있어서의 흡광도를 측정하고, 양자의 차를 블루 포르마잔 생성량으로 하였다.Normal human neonatal foreskin epidermal keratinocytes (NHEK) were cultured using proliferation medium (EpiLife-KG2) for long-term culture of normal human epidermal keratinocytes, and then cells were recovered by trypsin treatment. The recovered cells were diluted with EpiLife-KG2 at a concentration of 1.5 × 10 4 cells / mL (for fermentation, fermented turmeric) or 2.0 × 10 4 cells / mL (for fermentation month), followed by collagen-coated 96 100 μL per well was seeded into well plates and incubated overnight. After the end of the culture, 100 μL of the test sample dissolved in EpiLife-KG2 was added to each well and incubated for 3 days. Epidermal keratinocyte proliferation promoting activity was measured using the MTT assay. After the end of the culture, the medium was removed, and 100 μL of MTT dissolved in PBS (−) at a final concentration of 0.4 mg / mL was added to each well. After incubation for 2 hours, the blue formazan produced in the cells was extracted with 100 μL of 2-propanol. After extraction, the absorbance at wavelength 570 nm was measured. At the same time, the absorbance at a wavelength of 650 nm was measured as turbidity, and the difference between them was defined as the amount of blue formazan produced.
표피각화세포 증식 촉진작용의 계산방법은 이하와 같다. 결과를 표 30~32에 나타낸다.The calculation method of the epidermal keratinocyte proliferation promoting effect is as follows. The results are shown in Tables 30 to 32.
표피각화세포 증식 촉진율(%) = St/Ct×100Epidermal keratinocyte growth rate (%) = St / Ct × 100
St: 피험시료를 첨가한 세포에서의 흡광도St: Absorbance in Cells Added Test Samples
Ct: 피험시료를 첨가하지 않는 세포에서의 흡광도Ct: absorbance in cells without addition of test sample
(실시예 8: UV-B 손상으로부터의 회복작용 시험)(Example 8: Recovery test from UV-B damage)
상기 각 식물 발효 추출물을 피험시료로서 사용하여, 하기의 시험방법으로 UV-B 손상으로부터의 회복작용을 시험하였다.Using each of the plant fermentation extracts as a test sample, the recovery from UV-B damage was tested by the following test method.
인간 정상 피부 섬유아세포(NB1RGB)를 10% FBS 함유 α-MEM을 사용하여 배양한 후, 트립신처리에 의해 세포를 회수하였다. 회수한 세포를 α-MEM을 사용하여 2.0×105 cells/mL의 농도로 희석한 후, 48 웰 플레이트에 1 웰당 200 μL씩 파종하였다. 24시간 배양한 후, 배지를 100 μL의 PBS(-)로 교환하고, 1.0 J/㎠의 UV-B를 조사하였다. 조사 후, 즉시 PBS(-)를 빼고, 10% FBS 함유 D-MEM에 용해한 피험시료를 각 웰에 400 μL 첨가하여, 24시간 배양하였다. 자외선 UV-B 손상으로부터의 회복효과는 MTT 어세이를 사용하여 측정하였다. 배양종료 후, 배지를 빼고, 종농도 0.4 ㎎/mL로 용해한 MTT를 각 웰에 200 μL씩 첨가하였다. 2시간 배양한 후, 세포 내에 생성된 블루 포르마잔을 2-프로판올 200 μL로 추출하였다. 추출 후, 파장 570 ㎚에 있어서의 흡광도를 측정하였다. 동시에 탁도로서 파장 650 ㎚에 있어서의 흡광도를 측정하고, 양자의 차를 블루 포르마잔 생성량으로 하였다. 또한, 마찬가지로 세포 파종한 후, UV-B를 조사하지 않는 세포, 및 세포 파종 후 UV-B를 조사하고 피험시료를 첨가하지 않는 세포에 대해서도 동일하게 측정하고, 각각 비조사군과 조사군으로 하였다.Human normal dermal fibroblasts (NB1RGB) were cultured using α-MEM containing 10% FBS, and then cells were recovered by trypsinization. The recovered cells were diluted to a concentration of 2.0 × 10 5 cells / mL using α-MEM, and then seeded in 200 μL per well in 48 well plates. After 24 hours of incubation, the medium was replaced with 100 μL of PBS (−) and irradiated with 1.0 J / cm 2 of UV-B. Immediately after irradiation, PBS (-) was removed immediately, and 400 µL of the test sample dissolved in 10% FBS-containing D-MEM was added to each well, followed by incubation for 24 hours. The recovery effect from ultraviolet UV-B damage was measured using an MTT assay. After completion of the culture, the medium was removed, and 200 μL of MTT dissolved in a final concentration of 0.4 mg / mL was added to each well. After incubation for 2 hours, the blue formazan produced in the cells was extracted with 200 μL of 2-propanol. After extraction, the absorbance at wavelength 570 nm was measured. At the same time, the absorbance at a wavelength of 650 nm was measured as turbidity, and the difference between them was defined as the amount of blue formazan produced. Similarly, the cells which did not irradiate UV-B after cell seeding and the cells which did not irradiate UV-B after cell seeding and did not add a test sample were measured in the same manner, and were set as non-irradiated groups and irradiated groups, respectively.
UV-B 손상 회복작용의 계산방법은 이하와 같다. 결과를 표 33~34에 나타낸다. The calculation method of a UV-B damage recovery action is as follows. The results are shown in Tables 33 to 34.
UV-B 손상 회복률(%) = {(Nt-C)-(Nt-Sa)}/(Nt-C)×100UV-B damage recovery rate (%) = {(Nt-C)-(Nt-Sa)} / (Nt-C) × 100
Nt: UV-B를 조사하지 않는 세포에서의 흡광도Nt: absorbance in cells not irradiated with UV-B
C: UV-B를 조사하고 피험시료를 첨가하지 않는 세포에서의 흡광도C: absorbance in cells irradiated with UV-B and without addition of test sample
Sa: UV-B를 조사하고 피험시료를 첨가한 세포에서의 흡광도Sa: absorbance in cells irradiated with UV-B and with test sample
실시예 1~8의 결과로부터, 발효 쑥의 추출물, 발효 버개스의 추출물, 발효 구아바의 추출물, 발효 씀바귀의 추출물, 발효 은자귀나무의 추출물, 발효 울금의 추출물, 및 발효 월도의 추출물은 피부 섬유아세포 증식 촉진작용, 트랜스글루타미나아제-1 생산 촉진작용, 엘라스타아제 활성 저해작용, MMP-1 활성 저해작용, 에스트로겐 유사 작용, I형 콜라겐 생산 촉진작용, 표피각화세포 증식 촉진작용, 및 UV-B 손상으로부터의 회복작용 중 적어도 어느 하나를 갖는 것이 확인되어, 이들의 사실로부터 발효 쑥의 추출물, 발효 버개스의 추출물, 발효 구아바의 추출물, 발효 씀바귀의 추출물, 발효 은자귀나무의 추출물, 발효 울금의 추출물, 및 발효 월도의 추출물이 항노화제의 유효성분으로서 적합하게 이용 가능한 것이 시사되었다.From the results of Examples 1 to 8, the extract of fermented mugwort, the extract of fermented bagus, the extract of fermented guava, the extract of fermented moth, the extract of fermented silverwood, the extract of fermented turmeric, and the extract of fermented moon Fibroblast proliferation, transglutaminase-1 production promotion, elastase activity inhibition, MMP-1 activity inhibition, estrogen-like action, type I collagen production promotion, epidermal keratinocyte growth promotion, and It has been confirmed that it has at least one of the action of recovery from UV-B damage, and from these facts, the extract of fermented mugwort, the extract of fermented bagasse, the extract of fermented guava, the extract of fermented moth, the extract of fermented silverwood, It has been suggested that the extract of fermented turmeric and the extract of fermented moonshine can be suitably used as an active ingredient of the anti-aging agent.
(배합예 1)(Compound Example 1)
-유액--latex-
하기 조성에 따라서 유액을 통상적인 방법으로 제조하였다.The emulsion was prepared according to the following composition in a conventional manner.
·발효 쑥의 50 질량% 에탄올 추출물 … 0.10 g· 50 mass% ethanol extract of fermented mugwort… 0.10 g
·호호바오일 … 4.00 gJojoba oil… 4.00 g
·1,3-부틸렌글리콜 … 3.00 g1,3-butylene glycol... 3.00 g
·폴리옥시에틸렌세틸에테르(20E.O.) … 2.50 gPolyoxyethylene cetyl ether (20E.O.) 2.50 g
·올리브오일 … 2.00 gOlive oil… 2.00 g
·스쿠알렌 … 2.00 g· Squalene… 2.00 g
·세탄올 … 2.00 gCetanol 2.00 g
·모노스테아르산글리세릴 … 2.00 g· Glyceryl monostearate… 2.00 g
·올레산폴리옥시에틸렌소르비탄(20E.O.) … 2.00 gOleic acid polyoxyethylene sorbitan (20E.O.) 2.00 g
·파라옥시안식향산메틸 … 0.15 g· Methyl paraoxybenzoate. 0.15 g
·황기 추출물 … 0.10 gAstragalus extract… 0.10 g
·글리시리진산디칼륨 … 0.10 g· Potassium Diglyceride Glycerate… 0.10 g
·은행나무잎 추출물 … 0.10 gGinkgo leaf extract 0.10 g
·콘키올린(conchiolin) … 0.10 gConchiolin... 0.10 g
·황백 추출물 … 0.10 gYellow-white extract… 0.10 g
·카밀레 추출물 … 0.10 gChamomile extract... 0.10 g
·향료 … 0.05 g·Spices … 0.05 g
·정제수 … 잔부(합계: 100.00 g)·Purified water … Remainder (total: 100.00 g)
(배합예 2)(Combination Example 2)
-화장수--toilet water-
하기 조성에 따라서 화장수를 통상적인 방법으로 제조하였다.Toner was prepared according to the following composition in a conventional manner.
·발효 버개스의 50 질량% 에탄올 추출물 … 0.10 g50 mass% ethanol extract of fermented bagasse. 0.10 g
·글리세린 … 3.00 g· Glycerin… 3.00 g
·1,3-부틸렌글리콜 … 3.00 g1,3-butylene glycol... 3.00 g
·올레산폴리옥시에틸렌소르비탄(20E.O.) … 2.00 gOleic acid polyoxyethylene sorbitan (20E.O.) 2.00 g
·파라옥시안식향산메틸 … 0.15 g· Methyl paraoxybenzoate. 0.15 g
·구연산 … 0.10 g· Citric acid… 0.10 g
·구연산 소다 … 0.10 g· Citric acid soda… 0.10 g
·유용성 감초 추출물 … 0.10 g· Soluble Licorice Extract 0.10 g
·해조 추출물 … 0.10 gSeaweed Extract… 0.10 g
·고삼 추출물 … 0.10 g· Ginseng extract… 0.10 g
·자일로비오스 혼합물 … 0.05 gXylobiose mixture. 0.05 g
·향료 … 0.05 g·Spices … 0.05 g
·정제수 … 잔부(합계: 100.00 g)·Purified water … Remainder (total: 100.00 g)
(배합예 3)(Combination Example 3)
-크림--cream-
하기 조성에 따라서 크림을 통상적인 방법으로 제조하였다.Creams were prepared in a conventional manner according to the following composition.
·발효 구아바의 50 질량% 에탄올 추출물 … 0.10 g· 50 mass% ethanol extract of fermented guava. 0.10 g
·스쿠알렌 … 10.00 g· Squalene… 10.00 g
·1,3-부틸렌글리콜 … 6.00 g1,3-butylene glycol... 6.00 g
·유동 파라핀 … 5.00 gFlow paraffin 5.00 g
·화이트 밀랍 … 4.00 gWhite Beeswax 4.00 g
·세탄올 … 3.00 gCetanol 3.00 g
·모노스테아르산글리세릴 … 3.00 g· Glyceryl monostearate… 3.00 g
·라놀린 … 2.00 g· Lanolin… 2.00 g
·올레산폴리옥시에틸렌소르비탄(20E.O.) … 1.50 gOleic acid polyoxyethylene sorbitan (20E.O.) 1.50 g
·파라옥시안식향산메틸 … 1.50 g· Methyl paraoxybenzoate. 1.50 g
·스테아르산 … 1.00 g· Stearic acid… 1.00 g
·효모 추출액 … 0.10 gYeast extract… 0.10 g
·차조기 추출액 … 0.10 g· Aperture extract… 0.10 g
·참피나무 추출액 … 0.10 g· Basswood extract… 0.10 g
·지유(오이풀; Sanguisorba officinalis) 추출액 … 0.10 gOil extract (Oigi; Sanguisorba officinalis)... 0.10 g
·향료 … 0.10 g·Spices … 0.10 g
·정제수 … 잔부(합계: 100.00 g)·Purified water … Remainder (total: 100.00 g)
(배합예 4)(Combination Example 4)
-팩--pack-
하기 조성에 따라서 팩을 통상적인 방법으로 제조하였다.The pack was prepared in a conventional manner according to the following composition.
·발효 씀바귀의 50 질량% 에탄올 추출물 … 0.20 g· 50% by mass ethanol extract of fermented clover. 0.20 g
·폴리비닐알코올 … 15.00 gPolyvinyl alcohol 15.00 g
·에탄올 … 10.00 g·ethanol … 10.00 g
·프로필렌글리콜 … 7.00 gPropylene glycol. 7.00 g
·폴리에틸렌글리콜 … 3.00 gPolyethylene glycol... 3.00 g
·세이지 추출액 … 0.10 gSage extract 0.10 g
·당귀 추출액 … 0.10 g· Angelica extract. 0.10 g
·인삼 추출액 … 0.10 gGinseng extract 0.10 g
·파라옥시안식향산에틸 … 0.05 gEthyl paraoxybenzoate... 0.05 g
·향료 … 0.05 g·Spices … 0.05 g
·정제수 … 잔부(합계: 100.00 g)·Purified water … Remainder (total: 100.00 g)
(배합예 5)(Compound Example 5)
-정제상 영양보조식품-Tablet Nutritional Supplements
하기의 혼합물을 타정하여, 정제상 영양보조식품을 제조하였다.The following mixture was compressed to prepare a dietary dietary supplement.
·발효 은자귀나무의 50 질량% 에탄올 추출물 … 30 g· 50 mass% ethanol extract of fermented herring tree. 30 g
·분당(粉糖)(자당) … 178 g· Bundang (sucrose). 178 g
·소르비트 … 10 gSorbite… 10 g
·글리세린 지방산 에스테르 … 12 gGlycerin fatty acid esters; 12 g
(배합예 6)(Combination Example 6)
-과립상 영양보조식품-Granular Supplements
하기의 혼합물을 과립상으로 형성하여, 과립상 영양보조식품을 제조하였다.The following mixture was formed into a granular form to prepare a granular dietary supplement.
·발효 월도의 50 질량% 에탄올 추출물 … 20 g· 50 mass% ethanol extract of fermentation month. 20 g
·라피노오스 … 1000 gRaffinose… 1000 g
·비타민 C … 167 gVitamin C... 167 g
·스테비아 추출물 … 10 gStevia extract 10 g
본 발명의 항노화제, 피부외용제 및 음식품은 우수한 항노화 작용을 갖기 때문에, 예를 들면 피부의 탄력성 저하, 거칠어짐, 주름 등의 피부 노화증상의 예방·개선을 목적으로 한 피부외용제나 음식품에 적합하게 이용 가능하다.Since the anti-aging agent, the external preparation for skin and food and drink of the present invention have excellent anti-aging action, for example, the external skin preparation and food and beverage for the purpose of preventing and improving skin aging symptoms such as decreased skin elasticity, roughness, and wrinkles. It can be used suitably.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090026398A KR20090103823A (en) | 2008-03-28 | 2009-03-27 | Anti-aging agent external preparation for skin, and food and drink |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPJP-P-2008-088532 | 2008-03-28 | ||
KR1020090026398A KR20090103823A (en) | 2008-03-28 | 2009-03-27 | Anti-aging agent external preparation for skin, and food and drink |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20090103823A true KR20090103823A (en) | 2009-10-01 |
Family
ID=41533332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090026398A KR20090103823A (en) | 2008-03-28 | 2009-03-27 | Anti-aging agent external preparation for skin, and food and drink |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20090103823A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015140470A3 (en) * | 2014-03-18 | 2016-01-21 | Greenpharma | Cosmetic and pharmaceutical applications of gallic acid and gallic acid derivatives |
FR3031455A1 (en) * | 2015-01-14 | 2016-07-15 | Greenpharma Sas | DERIVATIVE COMPOUND OF GALLIC ACID AND APPLICATIONS |
KR20210117517A (en) * | 2020-03-19 | 2021-09-29 | 주식회사 다솔 | Cosmetic composition comprising Alpinia Speciosa Leaf and illite as an active ingredient and method for manufacturing the same |
CN113631227A (en) * | 2019-03-29 | 2021-11-09 | 丸善制药株式会社 | Antiaging agent, antioxidant, antiinflammatory agent, whitening agent, and cosmetic |
-
2009
- 2009-03-27 KR KR1020090026398A patent/KR20090103823A/en not_active Application Discontinuation
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015140470A3 (en) * | 2014-03-18 | 2016-01-21 | Greenpharma | Cosmetic and pharmaceutical applications of gallic acid and gallic acid derivatives |
FR3031455A1 (en) * | 2015-01-14 | 2016-07-15 | Greenpharma Sas | DERIVATIVE COMPOUND OF GALLIC ACID AND APPLICATIONS |
CN113631227A (en) * | 2019-03-29 | 2021-11-09 | 丸善制药株式会社 | Antiaging agent, antioxidant, antiinflammatory agent, whitening agent, and cosmetic |
KR20210117517A (en) * | 2020-03-19 | 2021-09-29 | 주식회사 다솔 | Cosmetic composition comprising Alpinia Speciosa Leaf and illite as an active ingredient and method for manufacturing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5822423B2 (en) | Skin fibroblast proliferation promoter, transglutaminase-1 production promoter, elastase activity inhibitor, MMP-1 activity inhibitor, estrogen-like agent, type I collagen production promoter, and recovery agent from UV-B damage | |
JP4470212B2 (en) | Skin improver | |
JP5162174B2 (en) | Hair restorer and anti-obesity agent | |
KR20120046064A (en) | Glucose-free pineapple extracts and methods for preparing thereof and their use | |
JP5797372B2 (en) | Platelet aggregation inhibitor, stem cell growth factor (SCF) mRNA expression inhibitor, matrix metalloproteinase-1 (MMP-1) activity inhibitor, and matrix metalloproteinase-14 (MMP-14) activity inhibitor | |
KR20220110127A (en) | Composition for whitening cosmetics comprising supercritical mixed fermented extract of cone or leaf of Pinus koraiensis Siebold et Zucc | |
KR20090103823A (en) | Anti-aging agent external preparation for skin, and food and drink | |
JP6055667B2 (en) | Collagen production promoter | |
JP2003055244A (en) | Agent promoting hyaluronic acid production, cosmetics, food and beverage including the hyaluronic acid production-promoting agent | |
JP5867981B2 (en) | Matrix metalloproteinase-1 (MMP-1) activity inhibitor, estrogen-like agent, type I collagen production promoter, hyaluronic acid production promoter, and recovery from UV-B damage | |
JP2023118853A (en) | Anti-aging composition, anti-aging skin cosmetics and anti-aging food and drink | |
JP4672269B2 (en) | Anti-aging agent, platelet aggregation inhibitor, antioxidant, antiallergic agent, skin cosmetics and food and drink | |
JP5534654B2 (en) | Anti-inflammatory agent | |
JP2001316275A (en) | Collagen production promoter, estrogen-like agent, collagenase inhibitor, skin cosmetic, food and drink | |
KR20200038114A (en) | Composition for improving skin comprising an extract of Pueraria thomsonii or a compound derived therefrom | |
JP5307366B2 (en) | Hair restorer | |
JP5832714B2 (en) | Tyrosinase activity inhibitor and melanin production inhibitor | |
KR102212343B1 (en) | Composition for skin anti-aging or moisturization comprising extract of marian plum | |
JP5422137B2 (en) | Whitening agent, tyrosinase activity inhibitor, melanin production inhibitor, and skin external preparation for whitening | |
KR101695372B1 (en) | Composition for improving wrinkle and elasticity containing ribes nigrum extracts | |
KR102244585B1 (en) | Complex cosmetic composition for improving skin-aging | |
JP2009091302A (en) | Anti-inflammatory agent, immunostimulator, skin whitening agent, anti-aging agent, anti-obesity agent, external preparation for skin, and food/drink for cosmetological use | |
KR20220046162A (en) | Composition for improving skin conditions comprising the extract of Allium ulleungense | |
JP2010184873A (en) | Cosmetic and food or drink | |
JP2008308436A (en) | Antioxidant, anti-aging agent, anti-inflammatory agent, skin cosmetic, and food/drink for beauty culture |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |